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ABSTRACT 
Since the emergence of hydrogels as carriers for cells, bioactive molecules, and even metallic 
nanoparticles, there were extensive efforts to control the rate and direction of embedded 
molecular release, largely by additional chemical modification of gel-forming polymers. 
However, these approaches often encountered several challenges including the instability of 
molecular cargos, the extensive labor of synthesis and purification, and the uncontrollability of 
the molecular release direction. In contrast, many biological systems use their geometry to guide 
the release of their molecules or signals. Inspired by nature, this study presents unique 
approaches with advanced in situ formation techniques, which can overcome the problems and 
control the release direction and rate of the diverse embedded materials in a hydrogel. First, I 
demonstrated a self-folding, multi-walled poly(ethylene glycol) diacrylate (PEGDA) hydrogel 
tube. This tubular structure was obtained by in situ self-folding of a bi-layered PEGDA hydrogel 
patch constructed with gels of significantly different rigidity and expansion ratio. The radiuses of 
the resulting gel tubes were estimated with bilayer curvature equations and agreed with 
experimental data. Second, the resulting hydrogel was used to control the release rate and 
direction of embedded molecules by localizing the molecules in a center of the tube. A finite 
element method (FEM) based simulation was performed to explain the geometrical effect on 
controlling the molecular release. Additionally, the bilayered PEGDA hydrogel encapsulating 
VEGF was implanted on a chicken chorioallantoic membrane (CAM) to evaluate the 
neovascularization. Due to the spatiotemporal release of VEGF, the gel tubes significantly 
increased the density and diameters of blood vessels, compared to unfolded hydrogel patches and 
other ring-shaped hydrogels. Third, I presented a bio patch delivery system with minimal 
invasive manner by using the self-folding and unfolding technique. I assembled the hydrogel 
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patch with a sacrificial layer that can dissolve in media after a controlled time. This hydrogel 
patch self-folded into a compact tube shape and delivered via a catheter to a targeted area 
followed by unfolding to a patch after a particular time. Lastly, I reported an in situ synthesis of 
metal nanoparticle-hydrogel composite that can sustainably reduce the release rate of embedded 
metal nanoparticles. The resulting gel composite with antimicrobial property of embedded 
metallic nanoparticles could control bacterial cell growth in an aqueous media and also inhibit 
biofilm formation on a polymeric and metallic substrates coated with the gel composite. Overall, 
this study was conducted for enhancing the efficacy of molecular compounds used for various 
agricultural products, food additives, sensor devices, and clinical treatments. 
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CHAPTER 1 
 
HYDROGELS FOR MOLECULAR RELEASE: 
CHALLENGE AND OUTLOOK 
 
In this chapter, first, I summarize with a fundamental overview of prior studies and approaches 
taken in hydrogels to enhance controlled molecular release. Second, I highlight key challenges 
that should be still resolved relating with the prior approaches. Finally, I propose alternative 
strategies to overcome such challenges and the organization for the reminder of the dissertation. 
 
1.1 Hydrogels for drug delivery 
Hydrogels are cross-linked networks of hydrophilic polymers, capable of retaining large amounts 
of water while remaining insoluble and maintaining their three-dimensional structure. Since their 
discovery and application in the biomedical field by Wichterle et al. in the early 1950s, a series 
of hydrogels have been developed to use them for a broad range of biomedical and 
pharmaceutical applications, including contact lenses, tissue engineering, diagnostics and drug 
delivery.[1]  
 
Hydrogels are generally regarded as biocompatible materials because their high water content 
and soft nature render them similar to the natural extracellular matrix.[2] Furthermore, their 
porous structure along with the water content is extremely suitable to accommodate high loads of 
water-soluble compounds, like therapeutically active proteins and peptides, in a physiologically 
relevant setting. 
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Unlike other delivery systems (emulsified microparticles, etc.), where preparation conditions are 
sometimes detrimental to biomacromolecules (i.e. use of organic solvents and molecular 
denaturation processes, like homogenization, exposure to interfaces, etc.), hydrogel preparation 
procedures are beneficial in preserving molecular stability, as mild conditions (aqueous 
environment, room temperature) are typically adopted. Macromolecules can be physically 
incorporated in the hydrogel matrix, and their release is governed by several mechanisms, such 
as diffusion, erosion or combination of two mechanisms.[3] Hydrogels allow fine-tuning of the 
molecular release rate by tailoring their cross-link density via changes in polymer architecture, 
concentration, and the molecular weights.[4], [5] 
 
Among hydrogels, poly(ethylene glycol) (PEG)-based hydrogels were widely researched as 
synthetic hydrogels because of their versatility of chemistry and biocompatibility.[6], [7] PEG is 
a water soluble polymer composed of repeating ethylene oxide units. Structurally, PEG is polar, 
uncharged, hydrophilic polymer. PEG with proper molecular weights has its properties of low 
protein adsorption, low toxicity, and nonimmunogenicity.[8] PEG is a versatile building block 
for a variety of biomaterials since its physical and chemical properties can be modified by 
changing molecular weight, architecture (branched, star, or comb), and functional groups. 
 
1.2 Mechanism of PEG hydrogel formation: step-growth, chain-growth, or mixed-
mode gelation 
Even though diverse gelation methods (i.e., physical, ionic, or covalent cross-linking) can be 
used to form PEG hydrogels, covalently cross-linking gives relatively stable hydrogel structures 
with tunable properties like permeability, diffusivity, elastic modulus and swelling ratio. The 
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synthesis of covalently cross-linked PEG gels is generally processed by three categories: chain-
growth, step-growth, or mixed-mode chain and step growth.[9] 
 
The chain-growth polymerization is typically implemented with functional PEG molecules, such 
as poly(ethylene glycol) diacrylate (PEGDA). Reactive radicals, generated from thermal energy, 
redox reactions, or the initiator photo-cleavage, initiate polymerization. The chain growth 
gelation occurs when free radicals propagate through unsaturated vinyl bonds on the PEG 
monomers. One advantage of this gelation is that functionalities can be expanded through the 
copolymerization of other functional acrylated macromers. Photo-polymerization is one of the 
preferable methods to assemble PEGDA hydrogels because of the short gelation time. One 
possible drawback of chain-growth polymerization, compared to step-growth mechanism, is that 
it can have lower conversion of the functional groups. Therefore, when the chain-growth 
polymerization is used to from implantable gels in situ, remaining monomers or functional 
groups in the hydrogel may cause local inflammatory reaction or immune response. [10] 
 
For the step-growth gelation, a multi-functionalized molecular system is cross-linked using bi-
functionalized molecules in a stoichiometric manner by the reaction between the 
functionalities.[11] Unlike the chain-growth mechanism, this reaction can be performed under 
ambient conditions without initiators, and it makes fewer structural defects during network 
formation. This allows more precise control of gel properties like cross-linking density and 
stiffness. Hubbell and colleagues developed the step-growth approach to form degradable 
hydrogels via Michael-type reaction between acrylated star PEG polymer and dithiol.[11], [12] 
One advantage to this technique is that the degradation of these gels does not generate high 
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molecular weight chains, which sometimes have problems like host inflammatory. When it 
comes to macromolecular delivery, the molecular damage is not caused by the propagation of the 
free radicals as occurred in chain-growth polymerizations. However, the presence of thiol groups 
may reduce the native disulfide bonds of the biomacromolecules and cause denaturation of the 
molecules.  
 
PEG hydrogels formed by mixed-mode gelations utilize characteristics between chain and step-
growth gelations.[13] This mixed-mode gelation overcomes the long gelation time required in 
most of the Michael-type reaction. Also, functional macromers like peptides can be incorporated 
at lower concentrations. Dissimilar to thiol-acrylate Michael addition reaction, thiol-acrylate 
photopolymerization is involved. The presence of photoinitiators increases the gelation rates as 
more thiol groups were added. Unlike chain-growth gelation, the initiator is not required in 
mixed-mode photopolymerizations; initiator-free gelation using mixed-mode has been studied. 
 
1.3 Prior approaches to control molecular loading and release in PEG hydrogels 
Drug molecules can be homogeneously loaded into hydrogel matrices through either post-
fabrication (i.e., drugs are loaded by incubating gels in drug-dissolved solution after gel 
fabrication) or in situ encapsulation (i.e., drugs are encapsulated by cross-linking of polymers). 
While the post-fabrication method ensures drug stability, accurate control over the amount of 
drug loading is not allowed because of limited diffusion partitioning. In addition, formulating 
hydrogels with multiple drugs at controllable levels is problematic. On the other hand, in situ 
encapsulation method can be used to prepare hydrogels with controlled amount of drugs while 
gelating molecules such as radical initiators can be detrimental to the embedded molecules.  
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The drug release mechanisms from hydrogels depend on multiple factors, including the method 
of drug loading, the size of the molecule, and the property of molecules. One easy way to control 
the drug release rate from a hydrogel is to modify the gel permeability by changing cross-linking 
density of a hydrogel. However, this approach is limited because hydrogels have intrinsically fast 
diffusion. Increasing cross-linking density often reduce cytocompatibility because of decreased 
hydrophilicity. Therefore, other controlling mechanisms should be considered to have more 
refined controllability and availability of the molecular release from a hydrogel. In the past, 
diverse prior approaches have been conducted as summarized below: 
 
Stimuli-sensitive hydrogel for drug delivery: 
Many types of hydrogels that can change their swelling ratio in response to external stimuli have 
been developed and applied for the controlled drug release.[14] Physiological change (e.g. 
temperature, pH, and ionic strength) stimulates the hydrogel to switch from a collapsed to 
swollen state. When the hydrogels are in collapsed state, the matrix limits the release of 
encapsulated drugs. On the contrary, when the physiological stimuli reach to the hydrogel's open 
condition, the drugs are released. 
 
Chemically-coupled PEG hydrogel: 
Therapeutic drugs can be covalently coupled to PEG hydrogel matrices via pendant functional 
groups. The degradable linkers between the tether and the drug can be used for pre-determined 
liberation and release rates. Diverse mechanisms of degradable linker have been proposed 
including hydrolytic and enzymatic degradation.[15] One drawback of this approach is that the 
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covalent conjugation of drugs to the linker may destabilize molecules, especially when fragile 
proteins and peptides are used as cargos. Furthermore, partially degraded linker fragments may 
cause unwanted host immune responses. 
 
PEG hydrogel having "affinity" to molecular cargos: 
“Affinity” hydrogels have been suggested for controlling drug availability in PEG hydrogels. By 
modifying the gel-forming polymers with oligopeptides or proteins that can physically associate 
with molecules of interest, inert PEG hydrogels can exhibit particular affinity toward the 
therapeutic molecules. One advantage of affinity hydrogels is that no direct chemical 
modification on fragile therapeutics is needed. A variety of affinity mechanisms has been shown 
to be effective in controlling drug availability in PEG hydrogels. For example, cyclodextrin can 
be conjugated into PEG hydrogels for the controlled release of small molecular weight 
hydrophobic drugs.[16] Also, heparin, a highly sulfated glycosaminoglycan (GAG), has been 
widely implemented to fabricate affinity hydrogels due to its reversible relationship to a variety 
of growth factors. However, the potential immunogenicity, non-specific binding with various 
proteins, and bleeding of heparin further complicate the release consequence in vivo. 
 
1.4 Goal of dissertation  
Even though there have been extensive efforts to control the rate of molecular release using 
chemically coupling method or affinity hydrogel, these approach still encountered several 
challenges including the instability of molecule, uncontrollability of release direction, and the 
extensive labor of synthesis and purification.  To resolve these problems, I introduce a new way 
to control the rate and direction of the molecular release by changing the hydrogel shape. A self-
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folding, multi-walled poly(ethylene glycol)diacrylate (PEGDA) hydrogel tube can sustainably 
release encapsulated molecules exclusively from its internal wall. Molecular release through the 
shape-changing hydrogel efficiently delivers therapeutic molecules in a local area with a 
sustained manner. This technique minimizes reaction steps and chemicals, thus preventing the 
molecular destabilization. In addition, this self-folding technique is used for therapeutic patch 
delivery with a minimal invasion for treatment of a large wound and tissue defect area. 
Furthermore, by extending this concept of controlling the molecular release, I attempt to control 
the release rate of embedded metallic nanoparticles in hydrogel systems, so as to use the 
resulting hydrogel composite for control of bacterial infection and biofouling.  
 
The reminder of this dissertation consists of four main chapters. 
 
In Chapter 2, I demonstrate the assembly of self-folding hydrogels with their physical 
characterization. This tubular structure was obtained by in situ self-folding of a bi-layered 
PEGDA hydrogel patch constructed with gels of significantly different rigidity and expansion 
ratio. Elastic modulus and expansion ratio of each hydrogel layer were tuned to control the 
degree of self-folding. The radius of the resulting self-folded hydrogel was also estimated with 
bilayer curvature equations.  
 
In Chapter 3, I demonstrate the ability of the self-folded gel to control direction and rate of the 
molecular release. Colorant molecules, bovine serum albumin (BSA) or vascular endothelial 
growth factor (VEGF) was used as molecular cargo. A finite element method (FEM) based 
simulation was also performed to address the geometrical effect on controlling molecular release. 
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Additionally, a self-folding hydrogel loaded with VEGF was used to demonstrate a self-folding 
capability in situ and also promote neovascularization at the implanted tissue. 
 
In Chapter 4, I present a minimally-invasive bio patch delivery system for organ therapy based 
on this self-folding technique. I assembled the double-layered hydrogel patch with a sacrificial 
layer that can dissolve in media after a controlled time. Using this gel system, I address an 
underlying mechanism by which the gel undergoes shape changes and also demonstrate a 
capability of the gel to be delivered through a catheter, then recovered its shape on a tissue 
membrane. 
 
In Chapter 5, I demonstrate a novel approach to securely fasten metallic nanoparticles in a 
PEGDA hydrogel. I fabricated the gel composites via in situ light-induced synthesis of silver or 
gold nanoparticles and cross-linking of gel-forming PEGDA. Using the gel composites, I will 
examine effects of the fabrication process on mechanical properties, nanoparticle retention, and 
anti-fouling/bacterial functionality. Finally, I will evaluate a possibility of using the gel 
composite as an anti-bacterial coating material of various polymeric and metallic substrates. 
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CHAPTER 2 
 
ASSEMBLY OF SELF-FOLDING HYDROGELS AND 
EXAMINATION OF PHYSICAL PROPERTIES 
 
Significant components of this chapter were published as “In Situ Self-Folding Assembly of a 
Multi-Walled Hydrogel Tube for Uniaxial Sustained Molecular Release” in Advanced Materials 
in 2013.[17] 
  
2.1 Introduction 
 Bimetallic strips have been used for a century to convert temperature change into mechanical 
displacement in varied mechanical and electrical devices.[18] The strip consists of two joined 
strip layers of different metals that expand at different rates as they are heated. The different 
thermal expansions force the flat strip to bend one way if heated, and in the opposite direction if 
cooled below its initial temperature. Similar to the bimetallic strip, I hypothesized that a bi-
layered hydrogel consisting of two hydrogels with different levels of water uptake self-folds in 
aqueous media. I examined this hypothesis using Poly (ethylene glycol) diacrylate (PEGDA) 
hydrogel with different molecular weight and concentration. PEGDA is one of the popular 
synthetic materials used to assemble a hydrogel using ultraviolet (UV) polymerization because of 
its unique hydrophilicity and biocompatibility. Also, the mechanical property and swelling ratio 
of the resulting gel are easily modulated by changing molecular weight and concentration.[19]  
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2.2 Results 
2.2.1 Fabrication of self-folding PEGDA hydrogel 
The bi-layered hydrogel patch was assembled by first preparing a thin hydrogel of PEGDA with 
a MW of 400 g mol-1, termed as PEGDA400, by exposing the pre-gel solution to UV light. 
Subsequently, another hydrogel layer was prepared over the PEGDA400 hydrogel by cross-
linking PEGDA with a MW higher than 400 g mol-1. The polymer concentration of each layer 
was kept constant at 20%. Each hydrogel thickness was kept constant at 200 µm. No physical 
separation was found between two gel layers (Figure 2.1).  
 
The subsequent immersion of the hydrogel patches in deionized water or phosphate buffer saline 
(PBS) triggered self-folding into a multi-walled gel tube, exclusively for the gel patches in which 
the top gel layer was prepared by cross-linking PEGDA with a MW larger than 1,000 g mol-1 
(Figure 2.2a & 2.2b). According to the magnetic resonance image of the gel tube, the 
PEGDA400 gel layer laden with iron oxide nanoparticles was wrapped by the higher MW 
PEGDA gel layer.[20] Therefore, the internal wall of the tube consisted of the PEGDA400 gel, 
while the external surface was the larger MW PEGDA gel layer (Figure 2.2c). 
 
2.2.2 Expansion ratio of hydrogel 
The geometries of the gel tubes were dependent on differences in the MW and concentrations 
between PEGDA gel layers (Figure 2.3). Increasing the MW of PEGDA in the top layer resulted 
in an exponential decrease in the elastic modulus and a linear increase of the one-dimensional 
expansion ratio as defined in Eq. (2.1), 
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! = !!!! !! − 1                                                              (2.1) 
where Qi and Qf are the degrees of swelling of a hydrogel before and after incubation in aqueous 
media, respectively (Figure 2.4). Specifically, bi-layered gel patches with 2 cm length and 2 cm 
width were self-folded into tubes with 2 cm length (Figure 2.5). The inner radius of the tube 
decreased from 9 to 0.7 mm by increasing the MW of the upper gel layer from 1,000 to 10,000 g 
mol-1 (Figure 2.2a & 2.3b). The same result was obtained with hydrogel strips with the same 
length that were 1 mm wide. The two-layered gel strips were self-folded into tubes with 1 mm 
length, while the inner radius of the tube was decreased by increasing the difference in MW. 
Additionally, this decrease in the inner radius was inversely related to thickness of the tube wall 
(Figure 2.3b). 
 
2.2.3 Control of inner radius of self-folding hydrogel with molecular weight 
To understand the underlying the mechanism, the inverse dependency between the inner radius 
of the gel tube and the difference of MW was fitted to a mathematical model originally 
developed to estimate the curvature of a heat-induced bimetallic strip (Eq. (2.2)), 
! = !!"∈ !!!! + 14+ !!!!                                                            (2.2) 
where r is the inner radius of the gel tube, E1 and E2 are the elastic moduli of the bottom 
PEGDA400 gel layer and the top PEGDA gel layer respectively, h is the thickness of each gel 
layer, and ε is the difference in the expansion ratio between two gel layers (!S).[21] This 
mathematical model therefore suggests that the larger ε leads to a decrease of r, coupled with the 
E1/E2. Incorporating measured E and ε into Eq. (2.2) resulted in estimations of r values which 
decrease by increasing the difference in MW of PEGDA between the two layers, similar to the 
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experimental results. More interestingly, these calculated r values agreed with the experimental 
values (Figure 2.3b). This result, therefore, suggests that the inverse relationship between the r 
value and the difference in MW of PEGDA is due to changes in ε and E1/E2. 
 
2.2.4 Control of inner radius of self-folding hydrogel with polymer concentration 
The inner radius and thickness of the gel tube was further modulated with the polymer 
concentration of the PEGDA400 gel layer (Figure 2.6). According to measurements of elastic 
moduli and expansion ratios of the gels, decreasing the concentration of PEGDA from 30 to 
10 % (w/w) significantly reduced the elastic moduli from 1.3 to 0.03 MPa and increased the 
degree of swelling from 5 to 10 (Figure 2.3c); however, there was a minimal change in the 
expansion ratio (Figure 2.7). Decreasing the polymer concentration of the PEGDA400 gel layer 
from 20 to 10 % (w/w) decreased the inner radius from 1.0 to 0.8 mm and also increased the wall 
thickness from 0.9 to 1.1 mm (Figure 2.3d). Again, this decrease in the inner radius of the gel 
was in agreement with the mathematical model noted in Eq. (2.2). These results show that the 
inverse relationship between the inner radius of the gel tube and polymer concentration of the gel 
is mainly related to changes in E1/E2.  
 
The inner radii of self-folded gel tubes were further related to the differences of cross-linking 
density between two gel layers (N), calculated by Eq. (2.4) in Table 2.1. The inner radius of the 
gel tube was exponentially decreased by increasing difference of N, which was tuned by altering 
difference of MW of PEGDAs used to prepare the bi-layered hydrogel patch (Figure 2.8a). In 
contrast, the inner radius of the gel tube was linearly increased with difference of N, which was 
tailored by altering concentration of PEGDA400 pre-gel solution in the bi-layered gel patch 
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consisting of PEGDA400 and PEGDA3400 gel layer (Figure 2.8b). Separately, cross-linking 
density of two gel layers was tailored to be similar to each other using PEGDA400 and 
PEGDA10000, in order to examine whether the gel still self-folds at zero-difference of N 
between two gel layers. The gel could still self-fold due to the difference of expansion ratio 
between two gel layers (Figure 2.9, Table 2.2). Taken together, we interpret that the self-folding 
mechanism is not simply explained by the difference of cross-linking density between two gel 
layers. 
 
 
2.3 Discussion 
These results demonstrate a multi-walled PEGDA hydrogel tube formed from the self-folding of 
a gel patch composed of two layers with different elastic moduli and expansion ratios. The 
differential stress between the two gel layers likely drove the self-folding process, as 
demonstrated through both experimental results and mathematical modeling. This self-folding 
process is distinguishable from other self-folding polymeric materials, with regards to the 
strategy of using differential stress.[22] Previously reported materials were largely constituted 
with chemically dissimilar materials which present different degradation rates and thermal 
sensitivities. Additionally, this study highlights that the difference of the expansion ratios 
between two gel layers determines the inner radius of the self-folded gel tube more 
predominantly than difference in the degree of swelling. 
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2.4 Conclusion 
Synthesis of a bilayer hydrogel with different level of water uptake resulted in multi-walled 
hydrogels in aqueous media. The wall thickness and radius of resulted gel tubes were calculated 
from elastic modulus and expansion ratio of each gel layer. The mathematical modeling was very 
well matched with experimental data. This self-folding property can be attained by pairing a 
wider array of hydrogel systems which react at the interface and exhibit significantly different 
expansion ratios, stiffness, or both. 
 
2.5 Materials and Methods 
Synthesis of PEGDA:  
 Poly(ethylene glycol) diacrylate (PEGDA) was synthesized via a chemical reaction between 
poly(ethylene glycol) (PEG, Sigma Aldrich) and acryloyl chloride (Sigma Aldrich).  First, PEG 
with varying molecular weights (MW ~ 1,000, 3,400 and 10,000 g/mol) was dissolved in 
dichloromethane at the concentration of 10 wt %.  Next, acryloyl chloride and triethylamine 
(Fisher Chemical) were dissolved in the PEG solution and stirred overnight under dry N2 gas.  
The molar ratio of PEG, acryloyl chloride, and triethylamine was kept constant at 1:4:4.  After 
24 hours, the product was precipitated by adding ice-cold ether.  The crude product was 
dissolved in deionized (DI) water and dialyzed for one day to remove unreacted starting 
materials and the salt byproducts.  Then, the product was freeze dried.  The conjugation of 
acrylate groups onto PEG was confirmed by 1H-NMR (300 MHz, QE300, General Electric).  
PEGDA with MW of 400 g/mol was used as received (Polysciences Inc.) 
 
Fabrication of a self-folding bi-layered PEGDA hydrogel: 
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 Pre-gel solutions were prepared by dissolving varying concentration of PEGDA (MW ~ 400, 
1,000, 3,400, 10,000 g/mol) in DI water, with 0.01 wt.% Irgacure 2959 (Ciba specialty 
chemicals) as a photo-initiator.  First, PEGDA400 solution was placed between two glass plates 
separated by a spacer with a 170 µm thickness.  Then, the gel solution was exposed to UV light 
(Jelight Co. Model 20, maximum UV wavelength 254 nm, distance between sample and lamp 1 
cm) for 5 minutes.  Second, the pre-gel solution of PEGDA with MW of 1,000, 3,400, and 
10,000 g/mol was placed on the PEGDA400 hydrogel surface using a spacer with 340 µm 
thickness.  Again, the pre-gel solution placed on top of the PEGDA400 gel was exposed to UV 
light for 5 minutes.  The resulting bi-layered hydrogel was cut into a patch with controlled 
widths and lengths for further characterizations.  Separately, the single-layered hydrogel of 
PEGDA with controlled MW was prepared in the form of the disks with a 1-cm diameter and 1-
mm thickness for measurements of elastic moduli and degrees of swelling. 
 
Hydrogel characterization: 
 Stiffness of the PEGDA hydrogel was evaluated by measuring an elastic modulus of the gel disk.  
Following incubation of hydrogel disks in DI water at 25°C for 24 hours, the gel disks were 
uniaxially compressed at a rate of 1 mm/min using a mechanical testing system (Insight, MTS 
Systems).  The elastic modulus was calculated from the slope of a stress vs. strain curve at the 
first 10% strain.  
 The degree of swelling was characterized with mass of water taken up by the gel.  First, mass of 
the hydrated gel was measured after incubation in DI water over 24 hours.  Then, the gel was 
lyophilized to measure the dried solid mass.  Finally, the degree of swelling was calculated from 
a mass ratio of the hydrated gel to the dried solid, Qm, using the Eq. (2.3), 
16 
 
! = !!!! = !!(!!!! + !!!)                                                     (2.3) 
where ρS was the density of water and ρP was the density of PEGDA. 
The cross-linking density was calculated using the Eq. (2.4), ! = !!!!/!!"                                                                      (2.4) 
where k is the stiffness, R is the gas constant (8.314 Jmol-1K-1) and T is the temperature at which 
the modulus was measured.  
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2.6 Figures 
 
 
 
Figure'2.1(Schematic(depicting(the(procedure(of(selfKfolding(hydrogel(fabrication.((1)(First(hydrogel(layer(
is(formed(between(two(glass(plates(with(a(200μm(thickness(gap(with(UV(irradiation.((2)(Second(layer(is(
formed(on(top(of(the(first(layer.((3)(Doubled(layered(hydrogel(is(immersed(in(DI(water.(
  
Gap:200μm)
Glass)
Hydrogel)prepolymer)solu4on)
(PEGDA400))
Ultraviolet)light)
Gap:400μm)
Glass)
Hydrogel)prepolymer)solu4on)
(PEGDA3400))
Ultraviolet)light)
Water)container)
Double)layered)hydrogel)patch)
(1))
(2))
(3))
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Figure'2.2(Fabrication(of(selfKfolding(PEGDA(hydrogel.((a)(Optical( images(of(selfKfolded(hydrogel(tubes.(
Images(in((b)(are(lateral(views(of(tubes(with(20Kmm(length(and(images(in((aK2)(are(crossKsectional(views(
of(tubes(with(1Kmm(length.(The(numbers(in(each(image(represent(the(MWs(of(PEGDA(used(to(prepare(
the( topKlayer( in( the( biKlayered( gel( patch.( Polymer( concentrations( of( the( bottom(PEGDA400( gel( layers(
and(the(top(high(MW(PEGDA(gel(layers(were(kept(constant(at(20(%((w/w).(All(scale(bars(represent(1(cm.(
(c)(A(magnetic(resonance(image(of(the(crossKsectional(view(of(the(multiKwalled(PEGDA(gel(tube,(in(which(
iron(oxide(nanoparticles(are(loaded(into(the(PEGDA400(gel(layer.(
400# 1000# 2000# 3400# 10000#
(a) 
2000# 3400# 10000#
(b) 
(c) 
PEGDA3400#layer#
PEGDA400#layer#
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Figure'2.3(Effects(of(different(molecular(weights((MW)(and(concentrations(of(PEGDA(hydrogels(on(the(
selfKfolding( of( the( biKlayered( PEGDA( gel.( (a)( The( elastic( moduli( (!)( and( expansion( ratios( (!)( of( the(
hydrogels(prepared(with(PEGDA(of(different(MWs.((b)(The(dependencies(of(the(inner(radii((!)(and(wall(
thicknesses((!)(of(the(gel(tubes(on(the(difference(in(the(MW(of(PEGDA(gel(layers.(Data(points(represent(
average( values( of( four( different( experiments( per( condition,( and( a( dashed( curve( represents( the(
simulated( result.( (c)( Elastic( moduli( (!)( and( expansion( ratios( (!)( dependency( on( the( PEGDA400(
concentration( in(the(biKlayered(gel(patch.( (d)(Dependencies(of(the( inner(radii( (!)(and(wall( thicknesses(
(!)(of(the(selfKfolded(gel(tube(on(PEGDA400(concentration(of(the(gel(layer.(A(dashed(curve(represents(
the(simulated(result.(In((c)(and((d),(the(biKlayered(gel(construct(was(constituted(with(the(PEGDA400(gel(
and(PEGDA3400(gel.(
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Figure'2.4(Schematic(depicting(definition(of(expansion(ratio((S).(
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Sample No Length (mm) Gel layer 1 Gel layer 2 
1 20 PEGDA400 PEGDA2000 
2 20 PEGDA400 PEGDA3400 
3 15 PEGDA400 PEGDA2000 
4 15 PEGDA400 PEGDA3400 
5 10 PEGDA400 PEGDA2000 
6 10 PEGDA400 PEGDA3400 
 
Figure'2.5(SelfKfolded(hydrogel(tubes(with(controlled(lengths(and(diameters.((a)(Top(views(of(the(gel(
tubes((b)(crossKsection(views(of(the(gel(tubes.(
  
(a) 
(b) 
Sample no. 1       2        3       4       5      6 
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Figure'2.6(Effects(of(PEGDA400(concentration(in(the(biKlayered(PEGDA(gel(construct(on(multiKwalled(gel(
tube(formation.((In(this(study,(the(other(gel(layer(in(the(biKlayered(gel(construct(was(prepared(by(crossK
linking(20(%((w/v)(PEGDA3400(solution.(((a)(Top(and(crossKsectional(views(of(the(multiKwalled(gel(tubes(
with(2(cm(length.(Concentration(of(the(PEGDA400(in(the(gel(layer(was(varied(from(10((1st(sample(from(
the(left)(to(15((2nd(sample),(and(20(%((w/v)((3rd(sample).((b)(CrossKsectional(view(of(the(multiKwalled(gel(
tubes(with(1(mm(length.(Concentration(of(the(PEGDA400(in(the(gel(layer(was(varied(from(10((1st(sample(
from(the(left)(to(15((2nd(sample),(and(20(%((w/v)((3rd(sample).(The(gel(tube(was(vertically(placed(on(top(
of(a(glass.(In((a)(and((b),(scale(bars(represent(2(mm.(
  
(a) 
(b) 
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Figure'2.7(Effects(of(concentration(of(PEGDA400(in(the(gel(on(the(swelling(ratio(and(expansion(ratio.(
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Figure'2.8(Relationship(between(the(inner(radius(of(the(selfKfolded(gel(tube(and(the(difference(of(crossK
linking(density((N)(between(two(gel(layers((a)(The(dependency(of(the(inner(radii(of(the(gel(tubes(on(the(
difference(of(N,(for(biKlayered(hydrogels(consisting(of(PEGDAs(with(different(molecular(weights((MWs).((
The( topKlayer(of( the(biKlayered(hydrogel(patch(was(prepared(by(altering(MW(from(1,000( (Dot(aK1),( to(
2,000( (Dot( aK2),( 3,400( (Dot( aK3),( and( 10,000( g/mol( (Dot( aK4).( ( The( PEGDA( concentration( was( kept(
constant( at( 20(%( (w/v).( ( The( bottom( layer( of( the( biKlayered( gel( patch(was( prepared(with( 20(%( (w/v)(
PEGDA(400(solution.(((b)(The(dependency(of(the(inner(radii(of(the(gel(tubes(on(the(difference(of(N,(for(
gel(patches(consisting(of(a(layer(of(20(%((w/v)(PEGDA(3400(gel(and(a(layer(of(PEGDA(400(gel(of(varying(
PEGDA400(concentrations.((PEGDA(400(concentration(was(varied(from(10((Dot(bK1)(to(15((Dot(bK2),(and(
20(%((w/v)((Dot(bK3).(
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Figure' 2.9( Image( of( the( gel( tubes( resulting( from( selfKfolding( of( the( biKlayered( gel( patch( consisting( of(
PEGDA400(gel(and(PEGDA10000(gel.((The(concentration(of(PEGDA400(and(PEGDA10000(were(10.3%(and(
20%,(respectively,(to(minimize(the(difference(of(crossKlinking(density(between(two(gel(layers((Table(2.2).(
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2.7 Tables 
 
Table' 2.1( Experimentally(measured( stiffness,( degree(of( swelling,(mathematically( calculated(expansion(
ratio(and(crossKlinking(density(of(each(hydrogels.(
MW (Conc.) k (kPa) Q S N (mol/m3) 
400 (10%) 29 11 0.08 5.2 
400 (15%) 343 5.9 0.08 76.7 
400 (20%) 644 4 0.08 164.1 
1000 (20%) 540 6.2 0.11 131.7 
2000 (20%) 269 10.1 0.21 60.9 
3400 (20%) 85 18.7 0.44 18.7 
10000 (20%) 40 38.9 0.80 8.6 
k: Stiffness, Q: Degree of swelling, S: Swelling ratio, N:Cross-linking density  
 
 
 
 
 
 
 
 
 
 
 
Table' 2.2( Experimentally(measured( stiffness,( degree(of( swelling,(mathematically( calculated(expansion(
ratio(and(crossKlinking(density(of(PEGDA400KPEGDA10000(hydrogels(formulated(to(present(the(minimal(
difference(of(crossKlinking(density(between(two(gel(layers.((
MW (Conc.) k (kPa) Q S N (mol/m3) 
400 (10.3%) 47 10.0 0.08 8.8 
10000 (20%) 40 38.9 0.80 8.6 
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CHAPTER 3 
 
GUIDE OF MOLECULAR RELEASE USING THE SELF-
FOLDING HYDROGEL 
 
Significant components of this chapter were published as “In Situ Self-Folding Assembly of a 
Multi-Walled Hydrogel Tube for Uniaxial Sustained Molecular Release” in Advanced Materials 
in 2013.[17] 
 
3.1 Introduction 
For the last several decades, hydrogels have been increasingly used to control the spatiotemporal 
distributions of various diagnostic and therapeutic bioactive molecules within tissues of interest 
through local and sustained molecular release.[9], [23] To attain this goal, extensive efforts have 
been made to control gel properties (i.e., degradation rates, interaction with bioactive molecules, 
etc) mainly by chemically modifying gel-forming polymers; however, these approaches often 
encounter several challenges including maintaining the structural integrity of the gels, the 
denaturation of macromolecules, and a limited transport of macromolecules into target 
tissue.[24], [25] To resolve these challenges, this study presents a simple, but unprecedented 
method to control the direction and kinetics of molecular release using a multi-walled 
poly(ethylene glycol) diacrylate (PEGDA) hydrogel tube formed by self-folding of a bi-layered 
gel patch. This self-folding property was attained by forming double-layered hydrogel patches 
with significantly different expansion ratios and elastic moduli. The diameter of the gel tubes 
could be predicted by an equation used to estimate the curvature of a bimorph beam. The 
resulting gel tubes exhibited a sustained release of molecules solely through its internal wall. 
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Multi-walled gel tubes were further used as a carrier of vascular endothelial growth factor 
(VEGF) to demonstrate that the unidirectional, sustained VEGF release significantly increased 
both the density and diameters of blood vessels around the implant site, compared to unfolded 
hydrogel patches. This multi-walled gel tube will greatly serve to improve the efficacy of various 
diagnostic and therapeutic molecules. 
 
 Prior approaches to control the release of molecules from hydrogels largely focused on 
chemically coupling molecules of interests to the gel-forming polymers using hydrolytically or 
enzymatically labile units.[26] Alternatively, efforts have been made to chemically modify gel-
forming polymers with oligopeptides or proteins that can physically associate with molecules of 
interests.[27] These approaches have demonstrated several impressive results; however, multiple 
chemical modifications and purification steps often increase material costs, and also readily 
denature the encapsulated compounds.[25] Additionally, the degradation process typically 
reduces a gel’s rigidity and resistance to fracture, thus leading to an undesirable structural 
disintegration of the gel at an implantation site.[28] The degradation may also expedite 
denaturation of compounds due to pH changes and the formation of reactive species.[29] 
Separately, the interface formed between a gel implant and the target tissue acts as a physical 
barrier that limits molecular diffusion into target tissue.[30] Microfabrication techniques have 
been used to introduce microchannels in a gel's structure, in order to facilitate the release of 
molecules into tissues; however, there is still a need to develop simpler processes that are 
compatible with a wide array of cross-linking mechanism used to fabricate and assemble 
hydrogel structures.[19], [31] 
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We hypothesized that a gel patch consisting of two layers with significantly different stiffness 
and capacities to uptake water would self-fold into a multi-walled gel tube when exposed to 
aqueous media. The resulting gel tube would display a sustained molecular release exclusively 
from the internal wall of the multiwall system (Figure 3.1). This hypothesis was examined by 
assembling a bi-layered gel patch, in which each layer consisted of PEGDA with different 
molecular weights (MW) and concentrations. The material’s ability to control the direction and 
rate of molecular release was examined by encapsulating a small colorant or bovine serum 
albumin (BSA) into an inner hydrogel layer of the gel tube. Finally, a bi-layered PEGDA 
hydrogel encapsulating VEGF was implanted on a chicken chorioallantoic membrane (CAM) to 
evaluate the in situ gel tube formation and neovascularization. 
 
3.2 Result 
3.2.1 Comparison of macromolecular release between self-folding hydrogels and patches 
The multi-walled PEGDA hydrogel tubes introduced in the Aim 1 study were used as a 
molecular releasing device by encapsulating bovine serum albumin (BSA) into the PEGDA400 
gel layer during the cross-linking reaction. Interestingly, the resulting gel tubes more sustainably 
released BSA than the unfolded gel patches (Figure 3.2a). The BSA-encapsulating single-layered 
PEGDA400 hydrogel patches displayed a large initial burst release of BSA, followed by rapid 
release. Therefore, most of the BSA loaded in the gel diffused out within 5 days. In contrast, 
multi-walled gel tubes exhibited an 80 % lower BSA burst for the first 24 hours. The release rate 
quantified with a first-order kinetic approximation, β in Eq. (3.1), was also 90 % lower for the 
multi-walled gel tube (Table 3.1), 
 !!"#!!"#,! = !!!"                                                                (3.1) 
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where CBSA is the amount of BSA remaining in the hydrogel at time t, and CBSA,O is the amount 
of BSA initially loaded in the hydrogel.[32]. Similarly, VEGF was released from the self-folded 
gel tube more sustainably than the gel patch (Figure 3.3). 
 
3.2.2 Simulation study of molecular release 
To further examine whether BSA is locally released from the internal wall of the tube, I 
estimated the concentration distribution of BSA discharged from the unfolded PEGDA hydrogel 
patches and the multi-walled gel tubes, using a diffusion-based finite element method (FEM) 
(Figure 3.2a & 3.2b). Diffusion coefficients for the BSA release in simulations were calculated 
from the experimental values displayed in Figure 3.1a, using Eq. (3.2), 
!!!! = 4( !"!!!)!/!                                                           (3.2) 
where Mt and M∞ are the cumulative amounts of drug released at time t and at an infinite time, 
respectively; D is the diffusion coefficient of the drug within the system; and L is thickness of 
the hydrogel patch or tube wall.[32] The released BSA amount estimated by the FEM-based 
simulation agreed with the experimentally measured values. 
 
This simulation also disclosed a continued increase in the local BSA concentration within the 
multi-walled gel tube, independent of the tube length. Furthermore, simulations were conducted 
to examine the diffusion of BSA and VEGF released from the multi-walled gel tubes into tissues 
for drug release applications. In the simulation, the self-folded gel tube with length of 1 mm was 
vertically implanted on tissue with the hydrogel ring and the strip as controls. The membrane 
implanted with the self-folded gel tube exhibited a more sustained increase of the amount of 
BSA than three other controls (Figure 3.4 & 3.5). The local increase of protein concentration was 
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attributed to the release of proteins from the inner layer of the gel tube. In contrast, other three 
control gel implants did not result in local increase of proteins in close proximity of gel implants. 
 
3.2.3 Colorant release from self-folding hydrogels 
To validate these simulation results, we incorporated a colorant, 2,2'-Bis(2,3-dihydro-3-
oxoindolyliden), into the PEGDA400 gel to monitor direction of molecule release within a short 
time period. Very interestingly, the colorant loaded into the multi-walled hydrogel tube with 2 
cm length was released exclusively through two open ends of the gel tube (Figure 3.2c). No 
significant circumferential diffusion of the BSA was observed. In the same manner, the gel tube 
with 1 mm length, which was vertically placed on a glass surface, also exhibited diffusion of the 
colorant through the internal wall (Figure 3.4c). 
 
3.2.4 Angiogenesis study with a chicken chorioallantoic membrane 
Finally, the gel tube encapsulating VEGF was implanted on a chicken chorioallantoic membrane 
(CAM) to test whether the local, sustained VEGF release stimulates vascularization at an 
implantation site (Figure 3.6). In this experiment, the bi-layered PEGDA gel encapsulating 
VEGF in the PEGDA400 gel layer was assembled into a strip with a 2 cm length and 1 mm 
width. Then, the bi-layered hydrogel strip was implanted on the CAM. The strip self-folded into 
a tube with 1.3-mm inner radius, 1-mm height, and 700-µm wall thickness within 10 minutes 
(Figure 3.7). Within 7 days, the VEGF-encapsulated self-folded hydrogel tube significantly 
stimulated blood vessel growth around the implant, as compared to other controls, including the 
VEGF-encapsulating hydrogel ring with 2.2-mm outer radius and 1.3-mm inner radius, VEGF-
encapsulated hydrogel disk with 2.2-mm radius and the VEGF-encapsulating PEGDA400 
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hydrogel strip. The VEGF amount loaded in each gel implant was kept constant at 60 ng, in 
order to examine effects of gel geometry on vascularization at the same VEGF dosage. 
 
According to previous studies, the VEGF dosage was large enough to stimulate vascularization 
in CAM, when VEGF was released from a hydrogel modified to degrade hydrolytically.[33] 
According to histological cross-sections of the tissues, the density of mature blood vessels 
positively stained by an antibody to α-smooth muscle actin was 1.5-fold larger for the VEGF-
releasing multi-walled gel tubes than hydrogel rings, and 2-fold lager than other control 
conditions (Figure 3.8 & 3.9a). Additionally, there was a significant increase in the fraction of 
blood vessels with larger cross-sectional areas of 3,000 µm2 or greater in the membranes 
implanted with the VEGF-releasing gel tubes, compared to other conditions (Figure 3.8 and 
3.9b). The PEGDA400 hydrogel rings and disks laden with VEGF resulted in limited vessel 
growth and even hydrogel strips showed similar vessel growth to the VEGF-free hydrogel tubes. 
 
3.3 Discussion 
The highlight of this study is that the resulting multi-walled PEGDA hydrogel tube can 
sustainably release biomacromolecules solely through two open ends. I suggest that this feature 
is attained for the following reasons: (1) a decrease in the surface area, (2) the presence of the 
multi-walls, (3) a sealing of the external tube surface by the blank gel layer, and (4) 
heterogeneously loaded drugs in a bi-layer. The self-folding process reduced surface area of the 
gel layer by 84%. The BSA or VEGF release rate should be significantly decreased in 
proportional to the surface area. Additionally, the blank hydrogel layers between the PEGDA400 
gel layers decrease the BSA diffusivity in the gel tube. Moreover, the blank gel layer on the 
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external surface likely acted as an insulator to prevent circumferential molecular release, similar 
to the myelin sheath which insulates neural axons.[34] This simple, but refined controllability of 
the direction and kinetics of molecular release at this time has not yet been reported using any 
self-folding polymeric constructs. 
 
Furthermore, this study demonstrated that the uniaxial, sustained VEGF release from the internal 
wall of a gel tube is more advantageous to promote vascularization than the gel strip or disk. I 
interpret that the VEGF released within the core of the tube diffused into tissue and sustainably 
stimulated vascular sprouting, although its efficiency may be mitigated by the structure and 
rigidity of target tissue.[35] In contrast, limited vascularization in tissue implanted with the 
VEGF-encapsulated gel ring, disk or strip is likely due to the minimal localization of VEGF in 
implanted tissue. This result is in accordance with previous studies that address the role of VEGF 
localization in guiding capillary sprouting.[31] 
 
3.4 Conclusion 
Overall, the multi-walled hydrogel tube will be useful for the local sustained delivery of a wide 
array of drug molecules, and subsequently improve the quality of molecular therapies. The self-
folded shape of gels may be readily controlled by altering geometry and shape of hydrogel patch 
using various microfabrication technologies. Also, this construct can further be advanced by 
loading multiple molecular compounds used for diagnostics, imaging, and treatments in separate 
layers. Instead of molecular compounds, the hydrogel can also be encapsulated with stem cells or 
islets capable or secreting multiple trophic factors, in order to release cell-secreted factors in a 
local and sustained manner.  
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3.5 Materials and Methods 
Analysis of macromolecular release from the hydrogel: 
 Bovine serum albumin (BSA, Sigma Aldrich) was loaded into the bottom PEGDA400 gel layer 
in the bi-layered gel, in order to characterize release properties of the hydrogel.  A bi-layered 
PEGDA400 hydrogel in which BSA was incorporated into only one of the layers was used as a 
control.  BSA was mixed with the PEGDA400 solution at a concentration of 1 % (w/w).  Then, 
the single-layered and bi-layered gels were prepared via photo cross-linking reaction, as 
described above.  The gel patch with 20-mm length, 20-mm width, and 1-mm thickness and the 
self-folded gel tube with 2-mm radius and 20-mm length were stored in a small vial filled with 3 
ml of phosphate buffer saline (PBS; pH 7.4, Cellgro), then incubated at 37 oC.  1 ml of PBS was 
collected from the each vial on a daily basis for 50 days, while keeping entire media volume 
constant at 3 ml using fresh PBS.  The concentration of BSA released into PBS was determined 
by the bicinchoninic acid assay (Micro-BCA, Thermo Scientific).  The Micro BCA assay was 
performed by pipetting three sample replicates (each 150 µl) to a 96-well plate, adding BCA 
reagent (150 µl) for each replicate and finally measuring the absorbance at 562 nm using a 
micro-plate reader (Tecan Infinite 200 PRO).  The BSA amount back-calculated from the 
measured absorbance was normalized by the total amount of BSA initially loaded into the gel, in 
order to quantify the cumulative percentage of BSA released. 
 
Separately, vascular endothelial growth factor (VEGF, R&D systems) was loaded into the 
bottom PEGDA400 gel layer in the bi-layered gel.  A bi-layered PEGDA400 hydrogel in which 
VEGF was incorporated into only one of the layers was used as a control.  VEGF was mixed 
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with the PEGDA400 solution at a concentration of 37.5 ng/mL.  Then, the single-layered and bi-
layered gels were prepared via photo cross-linking reaction, as described above.  The self-folded 
gel tubes and gel patches were stored in a small vial filled with 3 ml of phosphate buffer saline 
(PBS; pH 7.4, Cellgro), then incubated at 37oC.  1 ml of PBS was collected from the each vial 
on a daily basis for 7 days, while keeping entire media volume constant at 3 ml using fresh PBS.  
The VEGF concentrations in the media were measured using a VEGF ELISA kit (R&D systems), 
following the manufacturer’s protocol. The absorbance intensity of each wells was measured at 
450nm and corrected with the intensity at 570nm using a microplate absorbance reader (Synergy 
HT, Biotek). A calibration curve, prepared by measuring the absorbance values of standards with 
known concentrations of VEGF, was used to quantify the concentrations of VEGF in the 
collected cell culture media. 
 
Numerical Analysis: 
 3D finite element models for hydrogel constructs were created using Comsol Multiphysics 4.1.  
It was assumed that the drug release kinetics of the unfolded hydrogel patch and the multi-walled 
gel tube was governed by the Fick’s law of diffusion. Four hydrogels used in the model include 
(1) the multi-walled gel tube with 1-mm inner radius and 20-mm length, (2) the PEGDA400 gel 
patch with 20-mm length and 20-mm width, (3) the multi-walled gel tube with 1-mm inner 
radius and 1-mm length, and (4) the PEGDA400 strip with 20-mm length and 1-mm width.  The 
concentration of BSA in the unfolded gel patch and multi-walled gel tube was kept constant at 10 
mg/ml.  The CAM membrane was modeled as being 500 µm thick with a constant concentration 
of zero at the lower boundary of the model.  This constant concentration acted as a sink, thereby 
consuming the BSA or VEGF once it reached the bottom surface of the model.  The diffusion 
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across a boundary between two gel layers was assumed to be unobstructed.  In these numerical 
analysis, diffusion coefficients of BSA and VEGF in media, tissue, PEG3400 hydrogel, and 
PEG400 hydrogel were approximated to be 100 µm2/s, 1 µm2/s, 0.05 µm2/s, and 0.015 µm2/s, 
respectively.[36], [37] All simulations were in meters, seconds, and grams.  Each of the samples 
was modeled to simulate a period of 20 days.  
 
Neovascularization study using CAM: 
 Fertilized chicken eggs (Hy-Line W-36) were obtained from the University of Illinois Poultry 
Farm (Urbana, IL).  The eggs were initially incubated for 7 days, while being placed horizontally 
inside an incubator at 37 oC and 65 % humidity.  Next, a hole with a diameter of 2 cm was made 
on the top of the egg shells, and the samples were placed on the CAMs.  The eggs were 
incubated for 7 days at 37 oC, and the vascular networks in the CAMs were imaged using a S6E 
stereomicroscope (Leica) linked with a D-Lux E Camera (Leica).  All CAM experiments were 
performed under sterile conditions.  On the 7th day after implantation, the embryos were fixed 
with a 10% neutral buffered formalin solution (3.7 % formaldehyde in PBS).  The center of 
hydrogels and CAMs of each sample was excised.  The explants were embedded in paraffin, 
sectioned, and stained with an antibody to α-smooth muscle actin (αSMA). The density and 
numbers of positively stained blood vessels in tissue areas within a distance of 2 mm from the 
center of gel implants were quantified using image analysis software ImageJ (Figure 3.10).  The 
blood vessel densities were determined by measuring the total blood vessel area, and normalizing 
it to the total cross-sectional area of the CAM.  For each condition, 3 CAM samples were 
implanted and evaluated. 
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3.6 Figures 
 
 
 
 
Figure' 3.1( Schematic( depicting( multiKwalled( PEGDA( hydrogel( tube( that( sustainably( releases(
encapsulated(growth(factors(in(uniaxial(direction(and(subsequently(enhances(neovascularization((
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Figure'3.2'Experimental'and'computational'analysis'on'rate'and'direction'of'molecular'release'from'
the' unfolded' gel' patch' and' the' multiCwalled' hydrogel' tube.' (a)( The( BSA( release( profile( of( the(
PEGDA400( gel( patch( (!)( and( multiKwalled( gel( tube( (!)( consisting( of( a( PEGDA400( gel( layer( and(
PEGDA3400( gel( layer.( Data( points( represent( the( average( values( of( the( experimentally(measured( BSA(
amount(and(dashed(curves(represent(the(simulated(result.((b)(Simulated(concentrations(of(BSA(through(
multiKwalled(gel(tubes(with(1Kmm(radii(and(20Kmm(length((left(image)(and(PEGDA(400(gel(patches(with(
20Kmm( width( and( 20Kmm( length( (right( image)( after( incubation( for( 10( days.( Arrows( represent( the(
direction( of( BSA( release( through( the( hollow( core( of( the( tube.( (c)( An( optical( image( to( exhibit(
unidirectional( release( of( a( colorant,( 2,2'KBis(2,3KdihydroK3Koxoindolyliden),( through( two( open( ends( of(
the(gel(tube.( (
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Figure'3.3(The(VEGF(release(profile(of(the(PEGDA400(gel(patch((☐)(and(selfKfolded(gel(tube(consisting(of(
a(PEGDA400(gel(layer(and(PEGDA3400(gel(layer(( ).(
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Figure' 3.4'Numerical( and( experimental( analysis( of( BSA(distribution( released( into( a( tissue(membrane,(
following( the( release( from( the( gel( tube.( (a)( Numerical( analysis( of( BSA( concentrations( in( local( tissue(
membrane(implanted(with(the(selfKfolded(gel(tube,(the(gel(ring(and(the(gel(strip.(The(analyzed(area(of(
membrane( is(within(horizontal( radius(of(2(mm(and(vertical(distance(of(500(µm(from(the(center(of(gel(
implant.( (b)(Simulated(concentration(distribution(of(BSA(released( into( tissues( implanted(with( the(selfK
folded(hydrogel( tube(with(1Kmm(inner(radius(and(1Kmm(length((I),( the(hydrogel(ring(with(2Kmm(outer(
radius(and(1Kmm(inner(radius((II)(and(the(hydrogel(strip(with(1Kmm(width(and(20Kmm(length((III)((lower(
image),(after(five(days(of(implantation.(The(gel(tube(was(vertically( implanted.((c)(Optical(images(of(the(
colorant(released(into(the(hollow(core(of(the(gel(tube.(The(units(for(the(simulation(scale(bars(are(mmol(
mK3.( (
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Figure' 3.5( Numerical( analysis( of( VEGF( distribution( released( into( a( tissue( membrane,( following( the(
release(from(the(gel(tube.(((a)(VEGF(concentrations(in(CAM(implanted(with(the(selfKfolded(gel(tube,(the(
gel(ring,(the(gel(disk,(and(the(gel(strip.((The(analyzed(area(is(within(horizontal(radius(of(2(mm(and(vertical(
distance(of(500(um(from(the(gel(implant.(((b)(CrossKsectional(concentration(distribution(of(VEGF(in(CAM(
implanted( with( the( selfKfolded( hydrogel( tube( with( 1.3Kmm( inner( radius( and( 1Kmm( length( (I),( the(
hydrogel( ring(with( 2.2Kmm(outer( radius( and( 1.3Kmm( inner( radius( (II),( the( hydrogel( disk(with( 2.2Kmm(
radius((III)(and(the(hydrogel(strip(with(1Kmm(width(and(20Kmm(length((lower(image),(after(five(days(of(
implantation.(The(gel(tube(was(vertically( implanted.((IV).((c)(Top(view(of(concentration(distributions(of(
CAM(implanted(with(each(sample.((The(units(for(the(simulation(scale(bars(are(μmol/m3.(
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Figure'3.6(Schematic(depicting(the(inKvivo(CAM(experiment(procedure.(
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Figure' 3.7( Images(of( the( in!vivo!selfKfolding(of( the(biKlayered(PEGDA(hydrogel( strips(with(1Kmm(width(
and(20Kmm(length(on(CAM.(( (
5"min"1"min" 2"min" 4"min"
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Figure' 3.8'Optical( topKview( images(of(vascular(networks(and(microscopic( images(of(histological( crossK
sections(of(CAMs(that(were(stained(with(a(marker(for(αKsmooth(muscle(actin.(Samples(include(the(CAMs(
implanted(with(multiKwalled(hydrogel( tube(with(2.2Kmm(outer( radius,(1.3Kmm( inner( radius(and(1Kmm(
thickness( (I),( the( CAM( implanted(with( a( PEGDA400( gel( ring(with( 2.2Kmm( outer( radius,( 1.3Kmm( inner(
radius(and(1Kmm(thickness((II),(the(CAM(implanted(with(a(PEGDA400(gel(disk(with(2.2Kmm(radius(and(1K
mm( thickness( (III),( and( the( CAM( implanted(with( a( PEGDA400( gel( strip(with( 1Kmm(width( and( 20Kmm(
length( (IV).(All( samples(were( laden(with(VEGF(of(60(ng.(Concentrations(of(VEGF( in( the(hydrogel( tube,(
ring,(disk(and(strips(were(7.5,(7.5,(5.0(and(15.0(µg(mlK1,(respectively.' '
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Figure'3.9'Enhanced(vascularization(with(the(VEGFKreleasing(multiKwalled(hydrogel(tube.'(a)(Vascular(
densities(of(the(CAM(implanted(with(the(VEGFKencapsulating(gel(tube,(ring,(disk(and(strip.((b)(Analysis(of(
vascular(size(mitigated(by(the(VEGFKreleasing(devices.( (
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Figure'3.10(Schematic(showing(gel(implants(and(analyzed(area(of(CAM.(
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3.7 Tables 
 
 
 
 
 
Table 3.1 The release rate (β) and the coefficient of determination (R2) according to the first-
order kinetic approximation. 
 
 
 
  
 β R2 
Gel tube 1.68 x 10-3 0.9076 
Patch 19.1 x 10-3 0.8898 
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CHAPTER 4 
 
BIO-PATCH DELIVERY SYSTEM 
 
This chapter introduces the bio patch delivery system using self-folding technique.  
 
4.1 Introduction 
In the past several decades, a delivery of therapeutic nano or micro particles has shown great 
enhancement of therapeutic efficacy. However, particle delivery systems have had challenged 
with a treatment of a large local area such as organ surface treatment. Instead, researchers have 
made efforts to develop diverse bio-patches for therapeutics, diagnostics or imaging for the 
damaged tissue area.[38]-[42] For example, hydrogel bio-patches have been researched for 
therapeutic protein or growth factor delivery in a large local area. Similarly, stem cell sheets 
were studied to treat cardiovascular disease using its cell-based therapies.[31], [43] In addition, 
flexible electronic patches were developed to diagnose the organ's status by bonding the patch to 
the surface of organ.[44], [45] These bio-patches displayed impressive results and expanded the 
limit of nanoparticle treatment to a large local area on damaged organs. However, there have 
been no investigations about techniques to deliver the patches to target organ without invasive 
surgical procedures. Patients still need advanced materials that can be implanted on organs in a 
minimally invasive manner to meet the rapidly growing biotechnology. 
 
Here, we present the easily implantable hydrogel patch that is able to self-fold and unfold. This 
self-folding and unfolding property was obtained by bonding the sacrificial layer, which is rapid 
biodegradable and expandable hydrogel, to the therapeutic layer. This bi-layered hydrogel patch 
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self-folds to a small form of a gel tube in a short time, then unfolds to a patch by rapid 
degradation of a sacrificial layer in a controlled time at an implant site. This system is similar to 
the commonly used long sheet delivery such as carpets or metal sheets, but do not need 
additional machinery for folding. For a demonstration of this patch delivering technique, we 
implanted a gel patch on an egg embryonic membrane using a catheter via a small invasive hole. 
I propose this will greatly serve to develop biomedical materials for diagnostics, imaging, and 
treatments of organs. 
 
4.2 Results 
4.2.1 Self-folding/unfolding hydrogel 
In our previous research, PEGDA-PEI hydrogels consisting of poly(ethylene glycol) diacrylate 
(PEGDA, Mw=400 g mol-1) and polyethylenimine (PEI), which were formed through Michael-
type reaction between PEGDA and branched PEI, rapidly degraded over the course of several 
hours.[46] Their degradation times were controllable by changing concentration of PEGDA or 
PEI. We applied this unique hydrogel as a sacrificial layer functioning for self-folding/unfolding. 
On the other hand, PEGDA hydrogel, which have been conventionally used as a bio-patch for a 
drug and protein carrier, was used as a non-degradable therapeutic layer.[47] The bi-layered 
hydrogel patch composing of PEGDA-PEI hydrogel and PEGDA hydrogel was assembled by 
first preparing a thin therapeutic hydrogel layer of PEGDA (concentration of pre-gel solution 
was 20 weight %) with a MW of 400 g mol-1, by exposing the pre-gel solution to UV light. The 
concentration and molecular weight of the therapeutic layer were kept constant throughout this 
study. Subsequently, the sacrificial hydrogel layer (PEGDA-PEI) was prepared by pouring 
mixed PEGDA and PEI solution over the therapeutic hydrogel. Each layer thickness was kept 
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constant at 200 µm. Chemical reaction between PEI and the remaining acryl functional group of 
prefabricated PEGDA hydrogel layer occurred. Thus, no physical separation occurred between 
the two gel layers. The subsequent immersion of the hydrogel patches in deionized (DI) water or 
phosphate buffer saline (PBS) triggered self-folding into multi-walled gel tubes, and after a 
certain time, the self-folded gel tube unfolded to perfectly remained only the flat therapeutic gel 
layer (Figure 4.1 & 4.2). 
 
4.2.2 Physical kinetic property of PEGDA-PEI hydrogel 
To investigate the geometrical change of the bi-layered gel over time depending on the sacrificial 
layer composition, the elastic moduli and swelling ratios of PEGDA-PEI hydrogels with varying 
concentrations were measured over time, and the expansion ratio was calculated by the equation, 
! = !!!! !! − 1                                                    Eq. (4.1) 
where Qi and Qf are the swelling ratio of a hydrogel before and after incubation in aqueous 
media, respectively (Figure 4.3).[17] PEGDA-PEI hydrogel displayed a substantial increase of 
elastic modulus compared to only PEGDA hydrogel, and increasing PEGDA and PEI 
concentration significantly contributed to the increase of initial elastic modulus of PEGDA-PEI 
gels (Figure 4.3a-1 & 4.3b-1). However, the elastic modulus of gels rapidly decreased because of 
initial swelling process, then gradually approached zero by the degradation process (Figure 4.3a-
2 & 4.3b-2). In the same manner, the expansion ratio initially increased without a decrease in 
solid mass, yet as the expansion ratio reached higher values of 0.6, the solid mass of the hydrogel 
started to decrease significantly (Figure 4.3a-3 & 4.3b-3). The time required for complete 
degradation decreased from 80 minutes to 8 minutes with increasing concentrations of PEI from 
5% to 20% at a constant PEGDA concentration of 10 % (Figure 4.4a). On the contrary, the 
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complete degradation time was increased from 30 minutes to 210 minutes with increasing 
concentrations of PEGDA from 10% to 20% at a constant PEI concentration of 10 % (Figure 
4.4b). 
 
4.2.3 Radius change of self-folding/unfolding hydrogel over time 
To understand the underlying mechanism of radius change of self-folding hydrogel over time, 
the inner radius of the gel tube over time depending on the different MW of PEGDA or PEI for 
PEGDA-PEI gel was fitted to a mathematical model originally developed to estimate the 
curvature of a bimetallic strip with same thickness layers (Eq. (2)), ! = !!"∈ !!!! + 14+ !!!!                                               Eq. (4.2) 
where r is the inner radius of the gel tube, E1 and E2 are the elastic moduli of the bottom 
therapeutic PEGDA gel layer and the top sacrificial PEGDA-PEI gel layer respectively, h is the 
thickness of each gel layer, and ε is the difference in the expansion ratio between two gel layers 
(!S) (Figure & Chapter 4.2.6 for detailed calculation).[21], [48] The calculated minimum radius 
(r) of hydrogels during self-folding/unfolding process agreed well with the experimentally 
measured values. However, changing the composition of the PEGDA-PEI gel did not 
significantly affect on the minimal radius than varying the thickness of hydrogel layers. For 
example, the minimum radius of gel tube was ranged from 0.7 mm to 1.3 mm by changing 
PEGDA concentration on fixed 10% PEI, and was ranged from 1.3 mm to 1.5 mm by changing 
PEI concentration on fixed 10% PEGDA. On the contrary, thickness of gel layer massively 
affected on the minimal radius of gel tube. The minimal radius was 0.5mm to 5mm when 
thickness changes from 40 μm to 800 μm. This is explained from the Eq. (2) that the radius is 
linearly proportional to layer thickness. 
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In addition, the complete opening times of bi-layered gel tubes were measured and compared 
with the degradation time of PEGDA-PEI gel (Figure 4.6). The slope of linear fitting was 0.85 
and the correlation (r2) between complete opening time of gel tubes and gel degradation time was 
measured as 0.99. This result suggests that the PEGDA-PEI homogenously degrades and the 
complete gel opening time was controllable by changing the composition of PEGDA-PEI gel.  
 
4.2.4 Residual stress at the interface of hydrogel  
However, PEGDA(20%)-PEI(10%) condition made the gel fracture (Figure 4.7). To find the 
cause of the fracture, the residual stress at the interface between therapeutic layer and sacrificial 
layer was calculated from the measured elastic modulus and expansion ratio by !! = ∆∈!!!!!!!!! + !!!(!!!!!)!!(!!!!!)                                                Eq. (4.3) 
where σ is the maximum residual stress at the interface, E1 and E2 are the elastic moduli of the 
bottom therapeutic PEGDA gel layer and the top sacrificial PEGDA-PEI gel layer respectively, r 
is the inner radius of the gel tube, h is the thickness of each gel layer, and ε is the difference in 
the expansion ratio between two gel layers (!S) (Figure 4.8 & Chapter 4.2.6 for detailed 
calculation).[21], [48] Calculated residual stress at the condition of 20% PEGDA and 10% PEI 
reached 100 kPa during the process (Figure 4.8b). The therapeutic layer at the condition was torn 
during the self-folding/unfolding process because the therapeutic PEGDA gel layer could not 
endure the residual stress. This was confirmed by the performing the tensile stress test of 20% 
PEGDA therapeutic layer, which the layer had the fracture at 80 kPa with the maximum strain of 
0.16 (mm/mm) (Figure 4.8c & 4.8d).  
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4.2.5 Bio-patch delivery 
For the demonstration of the bio-patch delivery system, a chicken chorioallantoic membrane 
(CAM) was used as a model surface of tissue. A therapeutic PEGDA gel layer with 40 μm 
thickness and 10 mm diameter was prepared, and same thickness of PEGDA (10%)-PEI (5%) 
sacrificial layer was topped on the therapeutic layer (Figure 4.9a). When the bilayer gel was 
immersed in phosphate buffer saline (PBS) solution, it self-folded into a gel tube with 1 cm 
length and 1.5 mm outer diameter. After 30 minutes of incubation in PBS, the folded tube was 
transferred via PTFE tubes (1.8 mm inner diameter and 2.1 mm outer diameter) through an 
eggshell. For transferring gel tubes, only 2.3mm diameter of a hole was required and the hole 
size was significantly compared with the one (15mm) for conventional patch delivery (Figure 
4.9b). To see the process of unfolding of gel tube on CAM, the eggshell was opened and 
monitored with a video camera. The folded gel tube was completely unfolded on CAM within 30 
minutes (Figure 4.10). 
 
4.2.6 Calculation for radius and residual stress of bilayer hydrogel 
Next are the equations for a bilayer hydrogel with different expansions. This calculation is based 
on the next assumptions; 1) the materials are elastic. 2) Width of bilayer could be considered 
very small. 3) Expansion is uniform. 4) There is no separation between two layers. 
 
If two materials are separate, their lengths are different by different swelling ratio if there are no 
external forces.  However, if they are strongly bonded on the surface, internal forces (P1, P2) are 
created and also, bending moments (M1, M2) are created. Because there are no external forces, all 
forces over any cross-section should be in balance. 
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Force balance: ! ! !" = 0, !! = !! = !                                 Eq. (4.4) 
Bending moment: ! = !! +!! = !(!!!!!! )                             Eq. (4.5) 
where, b is width of two gel layer, h1 and h2 is the height of each gel layer. 
Strain (ε) caused by bending is calculated following equation, 
! = (! + !)! − !"!" = − !! 
where, R is the radius of the bended material, θ is the degree of angle and y is the distance from 
the interface. 
 
Bending moments for rectangular shaped materials are calculated following calculation. 
!! = !" !" = !!!" !" = !!! !! !" = !!! !! !" 
!! !" = 4 !! !2!!!! !" = 2! 13!! !!!! = ℎ!!12  !! = !!! ∙ !!!!" ∙ ! , !! = !!! ∙ !!!!" ∙ !                                        Eq. (4.6) 
 
At the interface, both materials' elongations are equal. The elongation includes the strain by axial 
force, and the strain by bending. 
!! + !ℎ!!!! + ℎ!2! = !! − !ℎ!!!! − ℎ!2! △ ! = !! − !! △ ! = !ℎ!!!! + !ℎ!!!! + ℎ! + ℎ!2!  !! ( !!!!! + !!!!!) =△ ! − !!!!!!!                                         Eq. (4.7) 
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Then, the curvature of bilayer is calculated by putting equation about P from the calculation of 
Eq. (4.5 & 4.6) into Eq. (4.7). ! = !! = !!!!!(!!!!!)!!!!∆!!!!!!!!!"!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!                  Eq. (4.8) 
If the thicknesses of both materials are equal (ℎ! = ℎ!), ! = !!"∈ !!!! + 14+ !!!!                                                       Eq. (4.9) 
The curvature is proportional to the difference in elongation of the two materials and inversely 
proportional to the thickness of the bilayer.  
 
Internal stress comprises two parts; 1) stress by axial force and 2) stress by bending moment, 
thus the internal stress is stated as y function. 
σ y =σ x +
Ey
R  
σ1 y=h1 =
P
bh1
−
E1h1
2R  
σ1 y=0 =
P
bh1
+
E1h1
2R  
σ 2 y=h2 =
P
bh2
−
E2h2
2R  
σ 2 y=0 =
P
bh2
+
E2h2
2R  
The maximum stress during expansion is produced in the interface between two layers.  
σ1 y=0 =
E1
h1E1 + h2E2
(h2E2Δε +
h12E1 − h22E2
2R )  
σ 2 y=0 =
E2
h1E1 + h2E2
(h1E1Δε +
h22E2 − h12E1
2R )  
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If the thicknesses of both materials are equal, maximum internal stress 
!! = ∆∈ !!!!!! + !! + ℎ!!(!! − !!)2!(!! + !!)  
 
4.3 Discussion 
 In chapter 2, we could understand the radius of self-folding hydrogel is determined by the elastic 
modulus and expansion ratio of each gel layer. Beyond the work, this study conducted the 
physical change of self-folding hydrogels over time with the kinetics of hydrogel degradation. 
PEGDA-PEI hydrogel degrades in a controlled manner by varying concentrations and this 
degradation determines the complete opening time and minimal radius of self-folding/unfolding 
hydrogels. Experimentally measured data was analyzed with relevant mathematical models. The 
mathematical model suggests that the inner radius of the gel decreases dominantly following the 
start of sacrificial layer's expansion because of increasing ε. However, after a certain time, 
decreased elastic modulus of sacrificial layer leads the increase of inner radius. This result, 
therefore, suggests that the relationship between the r value and PEGDA-PEI degradation over 
time is due to kinetic changes of dominancy in ε and E1/E2. Also, the slope between degradation 
time and complete opening was not 1, instead 0.85. This is explained that the stiffness of 
sacrificial layer becomes too week (E < 20 kPa) to endure the internal residual stress, thus 
fracture occurs in the sacrificial layer. Finally the gel tubes open up earlier than full degradation. 
 
 This hydrogel system for bio-patch delivery is highlighted in the regard that the safety of 
therapeutic layer should be guaranteed for delivering the patch. The stability of therapeutic layer 
was examined by monitoring with video and characterized by calculating the residual stress 
between two gel layers during the self-folding/unfolding process. First, because PEGDA-PEI 
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sacrificial layer is outer layer when it was self-folded, the therapeutic layer is protected inside 
during the process. Second, PEGDA-PEI degradation takes place all over the gel homogeneously, 
thus fairly homogeneous stress likely to be affected on entire gel during the process. This may 
not be achieved by other methods such as mechanical bending. Lastly, this system makes the 
hydrogels fold automatically without any human interaction involved. These advantages would 
be essential for delivering micro-sized fragile materials. 
 
This is the first conceptual bio-patch delivery system to the best of our knowledge. This 
delivering technique significantly reduced required size of invasion. The self-folding/unfolding 
hydrogels reduced its original surface area up to 70% and also reduced the required invasion area 
as 2.3% to the conventional invasion area. The minimally invasive surgery is much safer way 
than open surgery and prevents the diverse complications and infections. Also it allows the 
patients to recover much faster. By combining with robotic-assisted surgery, this bio-patch 
delivery system will greatly serve for developing more patient-friendly surgery. 
 
4.4 Conclusion 
Overall, self-folding/unfolding hydrogel was developed for bio-patch delivery with PEGDA-PEI 
fast-degradable hydrogel. Because of the misfit of expansion between the therapeutic layer and 
sacrificial layer, the bi-layered hydrogel self-folded in a form of multi-walled gel tubes in media 
and unfolded with the degradation of sacrificial layer. By tuning the degradation time of 
sacrificial layer, self-folding and unfolding time and rate were controlled. Bio-patch delivery 
using this technique was demonstrated with 2.3% of invasive area than the conventional method. 
This bio-patch delivery system will enable clinicians to use the modern medical techniques.  
58 
 
 
4.5 Experiments 
PEGDA and PEGDA-PEI hydrogels with various concentrations were synthesized and their 
elastic moduli and degrees of swelling were evaluated following our previous method. 20% (w/w) 
PEGDA (M.W. 400 g/mol) solution in DI water including 0.1% Igacure 2959 and was first 
polymerized by UV irradiation with the wavelength of 253 nm for 5 minutes between glass 
plates with different size of gaps. Then, a PEGDA-PEI hydrogel layer was prepared on the first 
layer by pouring the mixture of diverse concentration of PEGDA and branched PEI (M.W. 
1,000). Finally, the bi-layered gel was immersed in DI water or PBS to trigger self-folding into a 
hydrogel tube. For making thin film less than 200 µm thickness, a capillary force between 
glasses was used. Briefly, the solution was dropped on a 2 cm by 2 cm cover glass, and then a 
slide glass with 7.5 cm 2.5 cm was touched on top of the solution so that the solution can fill the 
area between the cover glass and the slide glass. A combined glass by a capillary force was 
hanged on supporters. The volume of solution was calculated by multiplying the needed 
thickness to 400 mm2. The hydrogels immerged in water was recorded by a video camera (Leica 
D-Lux) and the radius of hydrogel was analyzed from still cuts of videos. The measured values 
were compared with mathematically calculated radius.  
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4.6 Figures 
 
 
  
Figure'4.1'A'Schematic(image(depicting(the(process(of(selfKfolding/unfolding(hydrogel(formation.(
  
(1). Therapeutic layer 
(PEGDA hydrogel or 
PDMS)  
(2). Remained acrylate groups 
on surface 
(3). Formation sacrificial layer 
on top of the therapeutic layer 
(PEGDA-PEI) 
(4). Self-folding into a tubular 
hydrogel in water by expansion 
(5). Unfolding in the implantation site 
by degradation  
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Figure'4.2' Images(of(selfKfolding/unfolding(process(of(a(biKlayered(hydrogel(immersed(in(DI(water.(First(
layer(was(20%(PEGDA400(gel(and(second(layer(was(PEGDA(10%)KPEI(5%)(hydrogel. 
  
0"min" 2"min" 5"min"
55"min"58"min"60"min"
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Figure'4.3'Degradation(properties(of(PEGDAKPEI(hydrogel(with(varying(concentration(of(PEGDA(and(PEI.(
(aK1)( Initial(elastic(modulus( right(after( synthesis(with(varying(PEI( concentration(with( fixed(10%(PEGDA(
concentration.((aK2)(Elastic(modulus(and((aK3)(expansion(ratio(over(time(with(varying(PEI(concentration(
with( fixed( 10%( PEGDA( concentration.( (bK1)( Initial( elastic( modulus( right( after( synthesis( with( varying(
PEGDA(concentration(with( fixed(10%(PEI(cocentration.( (bK2)(elastic(modulus(and( (bK3)(expansion( ratio(
over(time(with(varying(PEGDA(concentration(with(fixed(10%(PEI(concentration. 
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Figure'4.4'unfolding(time(controls(by(varying(concentration(of(PEGDA(or(PEI.((a)(The(required(time(for(
selfKfolding/unfolding( gel( to( be( completely( unfolded( to( the( flat( patch( in( DI( water( by( varying(
concentration(of(PEI(with( fixed(10%(PEGDA.( (b)( The( required( time( for( selfKfolding/unfolding(gel( to(be(
completely(unfolded(to(the(flat(patch(in(DI(water(by(varying(concentration(of(PEGDA(with(fixed(10%(PEI. 
  
Unfolding time control on PEI 10%
5 10 15 20 25
0
50
100
150
200
250
PEGDA400 concentration (%)
C
om
pl
et
e
un
fo
ld
in
g 
tim
e 
(m
in
)
unfolidng time control on PEGDA 10%
0 5 10 15 20 25
0
20
40
60
80
PEI concentration (%)
C
om
pl
et
e 
un
fo
ld
in
g 
tim
e 
(m
in
)
(a)$ (b)$
63 
 
 
 
 
 
 
Figure' 4.5' Kinetics( of' SelfKfolding/unfolding( process( (aK1)( inner( radius( changes( over( time( while( selfK
folding/unfolding(with( varying( concentration( of( PEI( and( fixed( 10%( PEGDA.( (aK2)(Minimal( inner( radius(
during(the(process(of(folding/unfolding(from(the(hydrogels(with(varying(concentration(of(PEI(and(fixed(
10%(PEGDA.(Line(is(the(calculated(value(and(dots(are(experimentally(measured(data.((bK1)(inner(radius(
changes(over(time(while(selfKfolding/unfolding(with(varying(concentration(of(PEGDA(and(fixed(10%(PEI.(
(bK2)( Minimal( inner( radius( during( the( process( of( folding/unfolding( from( the( hydrogels( with( varying(
concentration( of( PEGDA( and( fixed( 10%( PEI.( Line( is( the( calculated( value( and( dots( are( experimentally(
measured(data. 
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Figure' 4.6' Correlation( between( complete( unfolding( time( and( full( degradation( time( of( PEGDAKPEI( gel(
layer.(
(
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Figure'4.7'Image(of(cracked(hydrogel(tube(during(the(selfKfolding/unfolding(process.(Sacrificial(layer(was(
PEGDA(20%)KPEI(10%).(Scale(bar(represents(1(mm.(
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Figure'4.8'Residual(stress(calculations(at(the( interface(of(two(gel( layers.' (a)'Residual(stress(changes(of(
therapeutic(PEGDA(gel(layer(over(time(at(the(interface(between(two(gel(layers(from(the(hydrogels(with(
varying(PEI(concentration(with(fixed(10%(PEGDA(or((b)(varying(PEGDA(concentration(with(fixed(10%(PEI.(
(c)( A( tensile( test( of( therapeutic( PEGDA( gel( layer.( Red( dash( line( represents( the( fracture( stress.( (d)(
Maximum( residual( stress( of( therapeutic( PEGDA( gel( layer( during( the( selfKfolding/unfolding( process( biK
layered(with(the(PEGDAKPEI(hydrogels(having(different(PEGDA(concentration(with(fixed(10%(PEI.(The(red(
line(represents(the(fracture(stress(of(therapeutic(PEGDA(gel(layer. 
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Figure' 4.9' (a)( Images(of(bioKpatch(delivery(process(on(CAM(through(an(eggshell.(PEGDA(10%)KPEI(5%)(
was( used( for( sacrificial( layer.( (b)( Comparison( of( invasion( area( between( (bK1)( selfKfolding/unfolding(
hydrogel(technique(and((bK2)(conventional(open(delivery. 
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Figure'4.10'Images(of'unfolding(process(of(selfKfolding/unfolding(hydrogel(on(CAM. 
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CHAPTER 5 
 
IN SITU IMMOBILIZATION OF METALLIC 
NANOPARTICLES IN A RIGID HYDROGEL FOR ANTI-
FOULING/BACTERIAL COATING 
 
In this chapter, I demonstrate a novel approach to immobilize metallic nanoparticles in a PEGDA 
hydrogel. Simultaneous light-induced synthesis of silver nanoparticles and cross-linking of gel-
forming PEGDA solution resulted in a rigid hydrogel sustainably usable for anti-
fouling/bacterial coating material. 
 
5.1 Introduction 
Bacterial contamination characterized by uncontrolled microbial growth in water and also on 
various industrial, household, and biomedical products negatively impacts on human health and 
welfare.[49]-[53] Metallic nanoparticles such as silver nanoparticles (AgNP) have been 
extensively studied to control the bacterial contamination.[54]-[56] Metallic ions dissolved from 
nanoparticles with a high surface area to mass ratio can damage bacterial cell membrane and also 
limit cell growth.[57], [58] These nanoparticles are often immobilized in a hydrogel, such that 
the resulting hydrogel composite can sustainably release metallic ions and subsequently control 
bacterial cell adhesion and growth over an extended time period.[59], [60] These nanoparticles 
are typically loaded into a pre-formed hydrogel via infiltration.[61] Alternatively, metal ionic 
precursors are infiltrated into a pre-made hydrogel, followed by activating reduction to form 
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metallic nanoparticles in the hydrogel.[62], [63] Conversely, gel-forming polymers mixed with 
pre-formed nanoparticles are cross-linked to assemble a gel composite.[64] 
 
The resulting composites demonstrated impressively enhanced anti-bacterial properties 
compared with free nanoparticles suspended in aqueous media or blank hydrogels. However, 
nanoparticles often rapidly diffuse out of the gel matrix, partly because of the absence of 
association between nanoparticles and a hydrogel matrix.[65] Such uncontrolled particle loss 
from the gel necessitates loading of a large amount of nanoparticles to attain desired performance, 
thus unintended raising concerns on health and environmental impacts of nanoparticles as well as 
material costs. Additionally, the increased loading of pre-formed nanoparticles reduces cross-
linking density of the gel, thus leading to significant decreases of mechanical stiffness and 
strength of the composite.  
 
To resolve these challenges, we hypothesized that simultaneous photo-activated synthesis with 
metallic nanoparticle-binding polymers would create a hydrogel composite with enhanced 
nanoparticle retention and minimal matrix softening. The resulting AgNP-laden gel composite 
will present improved anti-bacterial/fouling properties even with a smaller particle loading than 
that conventionally used. We examined this hypothesis by exposing a mixture of poly (ethylene 
glycol) diacrylate (PEGDA), vinylpyrolidone (VP), and metallic salt solutions including silver 
nitrate to ultraviolet (UV) lights (Figure 5.1). The poly(vinylpyrolidone) (PVP) is known to bind 
with silver nanoparticles via the coordination complex and van der walls interaction, while 
PEGDA allows us to control mechanical stiffness of the gel composite with its 
concentration.[66]-[68] A photo initiator activated by UV lights is capable of simultaneously 
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activating radical reduction of metal ions and cross-linking reaction of the PEGDA and VP. The 
nanoparticles formed in a gel were examined microscopically and spectroscopically while 
monitoring mechanical properties of the gel in parallel. Finally, we evaluated the extent to which 
the gel composite controls bacterial growth in broth media suspended with the gel composites 
and also biofilm formation on the gel. We further used the gel to coat polymeric/metallic 
substrates, in order to demonstrate usefulness of the gel as an anti-bacterial/fouling coating 
material. 
 
5.2 Result  
5.2.1 In situ fabrication of metallic nanoparticle-laden hydrogel composites  
Exposing the PEGDA solution mixed with silver nitrates to UV light resulted in hydrogels 
loaded with silver nanoparticles in situ, as demonstrated with color changes of the hydrogels and 
transmission electron microscopy images of the nanoparticles (Figure 5.2a & 5.2b). The average 
diameter of AgNP created in the hydrogel was approximately 8.5 ± 1.1 nm (Figure 5.2b & 5.2c). 
Similarly, photo-induced reduction of gold (III) chloride dissolved in the PEGDA solution also 
resulted in the gold nanoparticle (AuNP)-hydrogel composite. The diameter of AuNP formed in 
the gels was around 11.8 ± 2.0 nm. Both AgNP and AuNP formed in the gel presented a face-
centered cubic crystal structure with a lattice constant of 4.1 Å, as characterized with selective 
area diffraction patterns (Figure 5.3). 
 
The resulting AgNP and AuNP-hydrogel composite displayed the absorption in a visible area at 
the wavelength of 420nm and 530nm, respectively (Figure 5.4). Such surface plasmon resonance 
absorption was similar to the nanoparticles formed via conventional reduction of metal ions in 
71 
 
aqueous media.[69], [70] These nanoparticles remained stable in a gel over a month without any 
aggregation or precipitation. In contrast, nanoparticles prepared in the aqueous media aggregated 
within a few days, despite the presence of citrate-based capping molecules on the nanoparticle 
surface (Figure 5.5). 
The number of nanoparticles formed in the PEGDA hydrogel was further controlled with the 
irradiation time. The height of absorption peak at 420 nm was measured to estimate the 
concentration number of nanoparticles formed in a hydrogel following the principal of Beer-
Lambert law,  ! = − log!" !!! = !"#                                                            Eq. (5.1) 
where A represents absorbance; I0 and I are the light intensity before and after passage through the gel, ε 
is molar absorptivity, l is thickness of the gel through which the light passes, and c is concentration of 
nanoparticles.[71] At a given silver nitrate concentration, the absorption peak at 420 nm was increased 
with the irradiation time, specifically between 5 and 12 minutes (Figure 5.6a-1). In parallel, the number of 
cross-links for the PEGDA hydrogel was also increased with irradiation time, as demonstrated with the 
increase of UV absorbance below 400 nm wavelength. The peak represents n − π* to π − π* transition 
bands corresponding to a cross-linking reaction. (Figure 5.6b).[72] Similarly, the peak height at 350 nm 
was substantially increased between 5 and 12 minutes. 
 
The increase of the peak height was fit to a logistic curve, which follows an autocatalytic 
reaction model, ! = !!×!!(!!!!!)!!!"!!!                                                           Eq. (5.2) 
where Y is peak intensity at a given time t, YM and Y0 are maximum and minimum peak 
intensity values, k is the growth rate of nanoparticles or cross-links (Figure 5.6a-2 & 5.6b-2).[73] 
According to the calculation, k for the AgNP was 0.66 min-1, while k for the cross-links in the gel 
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was 0.69 min-1. These results therefore confirm that nanoparticles and gel were formed at the 
same rate.  
 
The number of nanoparticles formed in the gel was also controlled with concentration of metal 
ionic precursors. Both the yellow color intensity and the height of UV absorption peak of the 
AgNP-hydrogel composites increased with the concentration of silver nitrate (Figure 5.7). 
 
Further incorporation of VP into the PEGDA hydrogel slowed down both the reduction rate of 
nanoparticles and polymerization because the UV light at the wavelength of 253 nm, which was 
used for in situ gelation and particle polymerization, was likely absorbed by the PEGDA-PVP 
hydrogel more than the PEGDA hydrogel (Figure 5.8). However, after completion of the reaction 
in 30 minutes, minimal difference of the number of AgNP was found between the PEGDA 
hydrogel and the PEGDA-PVP hydrogel. 
 
5.2.2 In situ nanoparticle assembly minimally changes stiffness of the AgNP-hydrogel composite  
This in situ assembly of the AgNP-hydrogel composite minimally changed mechanical property 
of the hydrogel. Elastic moduli of both AgNP-PEGDA hydrogel composite and pure PEGDA 
hydrogel were approximately 900 kPa (Figure 5.9a). Interestingly, the elastic modulus of the gel 
composite was independent of silver precursor concentration in the pre-gelled mixture. The 
swelling ratio of the gel was also independent of the silver nitrate concentration. The same 
finding was made with the in situ AuNP-PEGDA hydrogel assembly (Figure 5.9b). These 
independencies of elastic modulus and swelling ratio on the silver precursor concentration were 
also observed with the PEGDA-PVP hydrogel (Figure 5.9c).  
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In contrast, the control condition, which was prepared by mixing pre-made AgNP with pre-
gelled solution followed by activation of cross-linking reaction of PEGDA, displayed the linear 
decrease of an elastic modulus with silver precursor concentration (Figure 5.9a). Ultimately, the 
PEGDA solution mixed with pre-made AgNP at concentrations higher than 2 mM failed to form 
the gel. Again, the significant decrease of the gel stiffness was also found when the gel 
composite was prepared with the pre-made AuNP (Figure 5.9b). The inverse dependency of the 
elastic modulus on silver nitrate concentration was also observed with the PEGDA-PVP 
hydrogel composite. 
 
Overall, according to the number of cross-links in the gel calculated using an elastic network 
model (see Eq. (5.5) in the experimental section), in situ gel composite assembly minimally 
influenced the cross-linked structure of the gel, while the pre-made nanoparticles substantially 
reduced the number of cross-links between polymers (Figure 5.9d). The same results were also 
found with the PEGDA-PVP hydrogel system (Figure 5.9e). 
 
5.2.3 Analysis of nanoparticle retention in the hydrogels 
The gel composite prepared by the in situ assembly displayed enhanced retention of 
nanoparticles as compared with the two-step process in which pre-made nanoparticles were 
added into the PEGDA solution followed by activation of cross-linking reaction. Interestingly, 
during incubation of the gel composites in DI water over 5 days, the concentration of AgNP in 
the PEGDA gel, calculated with the UV absorbance decreased by 5 % (Figure 5.10a). During the 
same period, the hydrogel composite prepared by the two-step process displayed the release of 
more than half of the AgNP.  
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Separately, the gel’s capability to retain nanoparticles was evaluated by measuring contents of 
AgNP and silver ions in incubation media using the inductively coupled plasma-mass 
spectroscopy (ICP-MS). The gel composite prepared via in situ assembly exhibited much smaller 
releases of AgNP and ions than that prepared by the two-step process (Figure 5.10b). The release 
rates (β) of AgNP and ions were further quantified using a first-order kinetic approximation [Eq. 
(5.3)]  
                                                            Eq. (5.3) 
where, Mt and M∞ are the cumulative amounts of particles or ions released at time t and at an 
infinite time, respectively. The gel composite prepared via in situ assembly displayed 15 and 3-
fold lower β values for AgNP and Ag+ ions, respectively, than that prepared via the two-step 
process. 
 
More interestingly, addition of VP into the AgNP-PEGDA gel composite system further reduced 
both released amounts and rates of AgNP and Ag+ ions. Specifically, few AgNP were released 
from the PEGDA-PVP hydrogel prepared by the in situ assembly (Figure 5.10b-1). The β value 
of Ag+ ions was also 10-fold smaller than that for the gel composite prepared by the two-step 
process (Figure 5.10b-2). 
 
5.2.4 Antibacterial activities of the AgNP-hydrogel composite 
The function of the AgNP-hydrogel composite to control bacterial growth was evaluated by 
measuring bacterial growth rates in media immersed with the composite. The AgNP-gel 
composites were immersed in the lysogeny broth (LB) media suspended with gram negative 
bacteria Escherichia coli (E. coli) at a density of 1.5 x 106 (CFU)/ml. Without the gel composite, 
Mt
M∞
=1− e−βt
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the cell number analyzed with the optical density at 600 nm increased to 109 (CFU)/ml within 8 
hours (Figure 5.11a-1). The cell growth rate (GR) was quantified by fitting the curve of optical 
density over time to a modified Gompertz growth model (Eq. (5.4)), 
! = !! + !!!"# −!"# !!!!! × !! − ! + 1                                   Eq. (5.4) 
where Z is the viable cell count (log CFU/ml), Z0 is the initial log number of cells, ZM is the difference 
between the initial and final cell numbers, Lg is the lag time before the cell growth, and t is the sampling 
time.[74]  
 
The AgNP-PEGDA gel composite immersed into the cell media significantly influenced both Lg 
and GR. Increasing the initial silver concentration in the gel composite from 0 to 10 mM 
exponentially increased Lg (Figure 5.11a-2). GR was also decreased with increasing silver 
concentration (Figure 5.11a-3). In particular, the PEGDA gel composite loaded 10 mM silver, 
inhibited an increase of the cell number over 5 days.  
 
More interestingly, the AgNP-PEGDA-PVP gel composite further limited the cell growth even at 
the silver concentration of 0.2 mM (Figure 5.11b-2). The Lg was approximately 16 hours, which 
was comparable to that attained with the 2 mM AgNP-PEGDA hydrogel composite. The Lg was 
also about 3-fold longer than the 0.2 mM AgNP-PEGDA gel composite. The GR was also 
significantly decreased with addition of VP into the gel composite (Figure 5.11b-3). In contrast, 
the pure PEGDA-PVP hydrogel made minimal influences on both Lg and GR.  
 
Additionally, gel composites incubated in DI water over ten days were challenged with fully 
saturated E. coli (109 CFU/ml), in order to assess the long-term anti-bacterial activities of the gel 
composites. Only AgNP-PEGDA-PVP hydrogel composites prepared by the in situ assembly 
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lysed the bacterial cells by 80% and ultimately made the opaque bacterial cell suspension clear 
(Figure 5.12a). 
 
The assembly method and composition of the gel composite also orchestrated to control biofilm 
formation on the gel surface (Figure 5.13). As characterized with the tdTomato fluorescence-
expressing E. coli, the pure PEGDA hydrogel allowed active bacterial cell adhesion and growth 
on its surface during incubation at 37°C over 7 days (Figure 5.13-I). The AgNP-PEGDA gel 
composite prepared by the two-step process significantly decreased the number of fluorescent E. 
coli on the gel; however, a certain number of bacterial cells adhered to the gel surface and 
underwent growth (Figure 5.13-II). In contrast, both the AgNP-PEGDA gel composite and 
AgNP-PEGDA-PVP gel composite prepared by in situ assembly inhibited cell adhesion and 
growth (Figure 5.13-III & IV).  
 
5.2.5 Evaluation of the AgNP-hydrogel composite as an anti-bacterial coating material 
The resulting AgNP-PEGDA-PVP hydrogel composite was used as an anti-bacterial/fouling 
coating material for various substrates including nylon and aluminum foil (Figure 5.14a). A thin, 
AgNP-hydrogel composite layer could be prepared by first coating substrates with poly(glycidyl 
methacrylate) (PGMA) and then spraying pre-gelled mixture followed by UV irradiation (Figure 
5.14a).[75] Interestingly, the coated nylon and aluminum substrates could minimize adhesion of 
bacterial cells, when they were challenged with the fully saturated (109 CFU/ml) tdTomato 
fluorescence-expressing E. coli at 37°C over 10 days (Figure 5.14b & 5.14c). In contrast, 
uncoated substrates displayed strong red fluorescence from metabolically active bacterial cells. 
According to electron microscopic images of E. coli collected from the incubation media, cells 
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incubated with uncoated substrates kept their cell membrane intact (Figure 5.14d-1). In contrast, 
cells incubated with the coated substrates were mostly punctuated and lysed (Figure 5.14d-2).  
 
5.3 Discussion 
Taken together, this study successfully demonstrated that photo-activated in situ AgNP and 
PEGDA-PVP gel assembly is advantageous to fabricating a sustainable anti-bacterial/fouling 
hydrogel composite. We suggest that the gel softening caused by loading of pre-fabricated 
nanoparticles in the pre-gel solution is attributed to the limited cross-linking reaction between 
gel-forming polymers particularly on the nanoparticle surface. Accordingly, the resulting gel 
would present reduced number of interconnected polymeric networks responsible for elastic 
response. As the number of defects is increased with nanoparticle concentration, the gel becomes 
softer proportionally to the number of particles loaded into the gel. In addition, uncontrolled 
aggregation between nanoparticles in the pre-gelled mixture would signify the gel softening. In 
contrast, the in situ nanoparticle synthesis and gelation minimized the nanoparticle-induced 
interferential effects on cross-linking between polymers likely due to balanced nanoparticle 
growth within space between cross-links. This interpretation is supported by formation of fairly 
monosized nanoparticles and also minimal aggregation within the gel matrix. Therefore, this in 
situ assembly method enabled us to decouple the inverse dependency between mechanical 
properties of the gel composite and nanoparticle concentration, and further allow us to 
broadening the range of nanoparticle loading. In addition, this in situ one-step assembly allows 
us to avoid using reducing agents for nanoparticle synthesis. There is a possibility that the 
reducing agents remain in a gel matrix and negatively impact on environment and human 
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health.[76] To the best of our knowledge, such nanoparticle-induced matrix softening was 
neither addressed nor resolved to dates. 
 
Furthermore, this study demonstrated that the resulting AgNP-PEGDA-PVP hydrogel composite 
could be used as an anti-bacterial material to inhibit bacterial growth in a media and also biofilm 
formation on material surfaces even with a smaller dose of AgNP than that used in past studies. 
Such result was achieved by the enhanced binding between AgNP and the gel matrix, as 
confirmed with minimal release of nanoparticles and ions from the gel matrix. We suggest that 
the improved nanoparticle and ion retention in the gel is caused by coordination between of 
tertiary amides of PVP with silver ions.[66] Therefore, the AgNP and ions retained in the gel 
composite could effectively damage membrane of bacterial cells exposed to the gel surface. The 
underlying mechanism should be further systematically examined in future studies, because this 
is the first-time to demonstrate the importance of sustained presence of silver ions in a matrix for 
enhanced anti-bacterial control. In the past, certain studies reported that a material designed to 
rapidly release silver ions is more favorable to controlling bacterial cell growth in aqueous 
media.[77] 
 
5.4 Conclusion 
In conclusion, this study demonstrated that an advanced method to assemble the AgNP-PEGDA-
PVP hydrogel composite that is structurally durable and also controls bacterial adhesion and 
contamination with reduced amount of AgNP. The independency of the composite stiffness on 
the nanoparticle concentration, attained by the in situ assembly, was attributed to the balanced 
growth of nanoparticles and cross-linking reaction of polymers. The superior anti-bacterial 
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activity of the gel composite was attributed to the sustained presence of AgNP and Ag+ ions in 
the gel matrix, likely due to the coordination between AgNPs and PVP of the gel matrix. As such, 
polymeric and metallic substrates coated by the gel composite successfully inhibit biofilm 
formation on the surfaces. Overall, the AgNP-PEGDA-PVP gel composite developed in this 
study would also greatly serve to take the quality of anti-bacterial control to a next level, with 
reduced concerns on the use of AgNP, Additionally, the results of this study would be broadly 
useful to improving a ratio of performance to particle loading for a wide array of metallic 
nanoparticle-laden polymer composite systems. 
 
5.5 Method 
In situ assembly of AgNP or AuNP-hydrogel composites:  
The pre-gelled mixture was prepared by dissolving PEGDA (MW 1,000 g/mol, Polysciences 
Inc.), vinylpyrollidone (VP, Sigma-Aldrich), Irgacure 2959 (0.1%, Ciba-Giegy), and silver 
nitrate or gold (III) chloride. Concentrations of PEGDA and VP were kept constant at 20 and 
10 %, respectively. Concentrations of silver or gold salts were varied from 0.2 to 10 mM. The 
pre-gelled mixture was placed between two glass plates separated by a spacer with 1 mm 
thickness. Then, the mixture was exposed to UV light (Jelight Co. Model 20, maximum UV 
wavelength 254 nm) for 10 minutes. The distance between the pre-gelled mixture and the UV 
lamp was kept constant at 1 cm. The resulting AgNP or AuNP-hydrogel composites were cut 
into 5 mm-diameter disks for further analysis. 
 
Transmission Electron Microscope (TEM) analysis of AgNP or AuNP-hydrogel composites:  
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The hydrogel samples were fixed in a Karnovsky's Fixative in phosphate buffered 2% 
glutaraldeyde and 2.5 % paraformaldehyde and then washed in phosphate buffer saline solution. 
The samples were dehydrated in a series of increasing concentrations of ethanol. Acetonitrile 
was used as the transition fluid between Ethanol and the Epoxy. Infiltration series was done with 
an epoxy mixture using the epon substitute Lx112. The resulting blocks were polymerized at 
75 °C overnight, trimmed and ultrathin sectioned with diamond knives. Sections were examined 
with a TEM (Jeol 2100), at 200 kV acceleration voltage. 
 
Analysis of mechanical properties of the hydrogel composites:  
The elastic modulus of the gel composite was measured by uniaxially compressing the samples 
at a rate of 1 mm per minute using a mechanical testing system (MTS Insight). The slope of the 
stress versus strain curve was used to calculate the elastic modulus from the first 10% of strain. 
The number of cross-links (N) in the gel was calculated from the degree of swelling and elastic 
modulus using an elastic network model,  
 ! = !!!!/!!"                                                                 (5) 
where S is the shear modulus calculated from the slope of the σ versus (λ − λ-2) curve assuming 
that the hydrogel follows an affined network model (σ: stress, λ: strain), Q is the degree of 
swelling, R is the gas constant (8.314 Jmol-1K-1) and T is the temperature at which the S and Q 
were measured.[78]  
 
Inductively coupled plasma-mass spectroscopy (ICP-MS) analysis:  
To measure the total amount of nanoparticles formed in hydrogels, 0.5 cm3 of composites were 
prepared and rinsed three times for 12 hours. Then, AgNP-hydrogel composites were incubated 
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in 2 % ammonium persulfate solution to bleach out metallic nanoparticles in the gel. The silver 
concentration of the collected solution was measured using the ICP-MS (PerkinElmer - SCIEX 
ELAN DRCe). Separately, to measure release rates of AgNPs and Ag+ ions, 0.5 ml of hydrogel 
composites were prepared, rinsed three times for 12 hours, and incubated in centrifuge tubes with 
6 ml of DI water at room temperature. 1 ml of supernatant was collected every 24 hours and total 
amount of silver was analyzed by ICP-MS. Another 4 ml of supernatant was collected every 24 
hours. The nanoparticles were filtered through Amicon ultra centrifugal filter units (Cut-off MW 
~ 10,000 g/mol) by centrifugation. Then, silver ion content in the media was analyzed by the 
ICP-MS. The amount of released nanoparticles was calculated by subtracting the measured silver 
ion mass from the total silver mass.  
 
Analysis of anti-bacterial properties of AgNP-hydrogel composites: 
Fresh E. coli (K12 TB1) was inoculated on an agar gel plate and incubated at 37 ºC for a day, so 
the cells form colonies. One colony was transferred to 5 ml of LB media in a tube using a sterile 
pipette tip. The tube was vigorously shaken at 37 ºC for 10 hours. The bacterial suspension was 
diluted to 1.5 x 106 (CFU)/ml at which the optical density at wavelength of 600nm (OD600) 
became 0.01. The 20 µl of hydrogel composites were added into 96 well plates, followed by 
loading 150 µl of dilute bacterial suspension. The absorbance at wavelength of 600nm was 
measured for 24 hours using a microplate reader (Tecan Infinite 200 PRO), while shaking the 
plate by 2 mm amplitude. The absorbance was used to quantify the lag time and the rate of 
bacterial growth. The assay was performed with four replicates for each sample. 
 
Preparation of E. coli expressing tdTomato Fluorescence 
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Competent E. coli were obtained using a mix & go E. coli transformation kit (Zymo Reseach). 
0.5ml of fresh E. coli cultured overnight in LB was inoculated to 50 ml Super Optimal Broth 
(SOB) medium in a 500 ml culture flask. The culture flask was shaken vigorously at 37 ºC until 
the OD600nm became 0.6. The culture flask was then transferred to an ice bath. After 10 minutes, 
the cells were centrifuged at 3,000 rpm for 10 minutes at 0 - 4°C to make a pellet. The pelleted 
cells were suspended in 5 ml ice-cold 1X Wash Buffer and re-pelleted, again. Then, cells were 
re-suspended in 5 ml ice-cold 1X Competent Buffer. 50 µl of the competent cell suspensions 
were aliquot to sterile centrifuge tubes and stored in a -70 °C freezer for later uses. For 
transformation of cells, 1 µl of ptdTomato fluorescence plasmid DNA (Clontech Laboratories 
Inc.) was added to 50 µl of competent cells. The mixture was placed onto an agar-gel plate 
containing 0.1% Ampicillin (Gold Biotechnology Inc.) and incubated at 37 ºC. After 24 hours, 
red-colored colonies were grown on the agar-gel plate. 
 
Analysis of anti-bacterial property of AgNP-hydrogel composites: 
E. coli engineered to express tdTomato florescence was cultured in LB media supplemented with 
0.1% Ampicillin for 24 hours before the experiment. AgNP-hydrogel composites with the size of 
2 cm length x 2 cm width x 0.2 mm thickness were placed on the agar gel plate containing 0.1% 
Ampicillin. 100 µl of engineered E. coli was placed on surface of the hydrogel composites. The 
plate was incubated at 37 ºC for 7 days. After the incubation, the gel composites were detached 
from the agar gel. Then, cells attached to the gel composites were imaged using a laser scanning 
confocal microscope (Carl Zeiss LSM 700). The experiment was performed with two duplicates 
for each condition.  
 
83 
 
 
Analysis of the long-term anti-bacterial property of the AgNP-hydrogel composites:  
20 mm3 of AgNP-hydrogel composites were incubated in DI water at room temperature for 10 
days. DI water was replaced every day. The hydrogels were transferred to a 96 well plate. 150 µl 
of fully saturated E. coli suspension with 109 CFU/ml was added into each well. The plate was 
incubated at 37 ºC without shaking, so cells readily sediment on gel surfaces. After 24 hours, 
cells on the gel composites were imaged with an optical microscope. In parallel, OD600 of the 
each well was measured with a plate reader. The experiment was performed with 4 duplicates for 
each condition. 
 
 
Coating of nylon and aluminum substrates with AgNP-hydrogel composites:  
First, poly(glycidyl methacrylate) (PGMA) was synthesized by radical polymerization of 
glycidyl methacrylate (GMA, 97%, Sigma-aldrich). The mixture of 30% GMA and 1% of 
azobisisobutyronitrile (AIBN, 98%, Sigma-aldrich) in methyl ethyl ketone (MEK) was stirred at 
60 ºC for 6 hrs. The synthesized PGMA was purified by repeated precipitation in diethyl ether, 
followed by drying in vacuum. Nylons and aluminum foils treated by plasma cleaner (Harrick 
Plasma PDC-32G) for 1 min were dip-coated in 1% PGMA dissolved in MEK, and subsequently 
annealed at 110 ºC for 15 min. Next, the substrates were finally immersed in the acrylic acid to 
link PGMA with acrylic acid. Finally, pre-gelled mixture of PEGDA and VP was placed on 
surface of acrylic group-functionalized substrates followed by irradiation with UV light for 10 
min. Then, the resulting substrates coated by the AgNP-hydrogel composites were washed with 
DI water to remove excess unreacted chemicals. 
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Analysis of anti-bacterial properties of substrates coated by AgNP-hydrogel composites: 
Both coated and uncoated substrates were placed in a 6-well plate. 3 ml of fully saturated (109 
CFU/ml) E. coli expressing tdTomato fluorescence was introduced into the well. The samples 
were incubated at 37 °C for 10 days. After the incubation, samples were gently rinsed with DI 
water 3 times and fluorescence from cells attached to the surface was visualized using a stereo 
fluorescence microscope (Nikon SMZ800). The fluorescence of substrates was measured using a 
plate reader (Tecan Infinite 200 PRO), in parallel. The substrates were excited at wavelength of 
540 nm, and the subsequent emission yield at 581 nm was measured. The experiment was 
performed with 4 duplicates for each condition. 
 
Morphological analysis of E. coli with a scanning electron microscope (SEM): 
The E. coli accumulated on substrates were collected by a sterile pipette tip and fixed in 4% 
formaldehyde solution. The cells were washed with DI water and centrifuged at 1,000 rpm for 5 
min. Then, the cells were dehydrated by repeatedly incubating them in ethanol-water mixture 
with increasing ethanol concentrations (i.e., 35%, 50%, 75%, and 100%). Between each step, the 
samples were centrifuged at 3,000 RPM for five minutes. The dehydrated cells were finally 
placed on a carbon tape and coated with platinum for charge dissipation. The morphologies of E. 
coli were observed using a scanning electron microscopy (Hitach 4800).  
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5.6 Figures 
 
 
 
 
 
Figure'5.1((a)(A(chemical(reaction(scheme(of(the(photoKactivated(reduction(of(metallic(salts(and(crossK
linking( of( PEGDAKPVP.( (b)( A( scheme( depicting(microstructural( changes( of( the( preKgelled(mixture( to( a(
nanoparticleKladen(hydrogel(composite.( (
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Figure'5.2(In!situ(assembly(of(AgNP(or(AuNPKhydrogel(composites'(a)(Optical(images(of(AgNP(and(AuNPK
hydrogel(composites.(0.2mM(of(silver(nitrates(or(gold((III)(chloride(was(mixed(with(the(preKgel(solution(
to( form( the( hydrogel( composites.( (b)( TEM( images( of( the( hydrogel( composites( laden(with( AgNP( (left(
image)( and( AuNP( (right( image)( formed( via( in! situ( assembly.( (c)( Size( distribution( of( AgNP( and( AuNP(
formed(in(the(hydrogel(composites.(Size(was(analyzed(using(TEM(images.(( (
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Figure' 5.3' Diffraction( patterns( of( (a)( AgNP( and( (b)( AuNP( formed( in( the( PEGDA( hydrogel( and( lattice(
constant(calculations.( (
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Figure'5.4(UV/Vis(absorption(spectra(of(AgNP(and(AuNP(formed(in(the(hydrogel(matrix.(
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Figure' 5.5'Optical( images( of( the( suspension( of( citrateKcapped(AgNP.( The( images(were( captured( right(
after(synthesis((aK1)(and(after(24(hours((bK1).(TEM(images(of(sodium(citrateKcapped(AgNP(captured(right(
after(synthesis((aK2)(and(after(24(hours((bK2).(
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Figure'5.6'Analysis(of(in!situ(AgNP(formation(kinetics(in(the(hydrogel'(aK1)(UV/Vis(absorption(spectra(of(
AgNP(formed(by(exposure(of(the(aqueous(mixture(of(0.2(mM(silver(nitrate(and(PEGDA(to(UV(light.((aK2)(
Increase(of(the(absorbance( intensity(of(AgNP(at(wavelength(of(420(nm(with(the( irradiation(time.((bK1)(
UV/Vis(spectra(of(the(PEGDA(hydrogel(acquired(at(different(irradiation(time(points.((bK2)(Increase(of(the(
normalized( peak( intensity( at( wavelength( of( 350( nm( over( time.( In( (aK2)( and( (bK2),( data( points( were(
normalized(by(feature(rescaling(method(in(the(range(of([0%,(100%](and(fit(to(the(sigmoidal(fitting.(
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Figure'5.7(Control(of(concentration(of(nanoparticles(formed(in(the(gel(by(varying(concentration(of(metal(
ionic( precursors.( (a)( Optical( images( of( the( AgNPKPEGDA( hydrogel( composite( prepared( with( varied(
concentrations( of( AgNO3.( (b)( UV/Vis( absorption( spectra( of( the( AgNPKPEGDA( hydrogel( composite(
prepared(with(varied(concentrations(of(silver(nitrate.(The(spectra(were(acquired(after(UV(irradiation(of(
preKgelled(mixture(over(10(minutes.((
  
PEGDA& 0.2mM& 2mM& 10mM&
(a) 
1 mm 
AgNP without Capping molecules
400 600 800
0.0
0.5
1.0
1.5
0.2mM
2mM
10mM
Wavelength (nm)
A
bs
or
ba
nc
e 
(A
.U
.)
(b) 
92 
 
 
 
 
 
 
 
 
Figure'5.8'(a)(UV/Vis(spectra(of(the(PEGDA(hydrogel(and(the(PEGDAKVP(hydrogel.((b)(Comparison(of(the(
absorbance(intensity(at(wavelength(of(250(nm(between(the(PEGDA(and(the(PEGDAKPVP(hydrogels.((
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Figure' 5.9' Analysis( of( physical( properties( and( crossKlinking( density( of( the( AgNPKPEGDA( hydrogel(
composites'(a)(Elastic(moduli(of(the(PEGDA(hydrogel(composites(laden(with(controlled(amount(of(AgNP(
prepared(either(by("in!situ"(assembly,(or("twoKstep"(assembly.(The(“in!situ”(assembly(was(conducted(by(
exposing(the(aqueous(mixture(of(metallic(salts(and(gelKforming(polymer.(The("twoKstep"(assembly(was(
conducted( by( incorporating( preKfabricated( AgNP( into( a( PEGDA( solution( followed( by( crossKlinking(
reaction.( (b)(Elastic(moduli(of( the(PEGDA(hydrogel(composite( laden(with(AuNP(prepared(either(by(“in!
situ”(assembly,(or(“twoKstep”(assembly.(((c)(Elastic(moduli(of(the(AgNPKPEGDAKPVP(hydrogel(composite(
prepared( either( by( “in! situ”( assembly,( or( “twoKstep”( assembly.( (d)( CrossKlinking( density( of( the(AgNPK
PEGDA(hydrogel(composites(and((e)(AgNPKPEGDAKPVP(hydrogel(composites(prepared(either(by(“in!situ”(
assembly,( or( “twoKstep”( assembly.(Data(points( and(error(bars( represent( average( values( and( standard(
deviation(of(3(different(samples.(( (
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Figure' 5.10( Analysis( of( capabilities( of( the( PEGDA( and( PEGDAKPVP( hydrogels( to( retain( metallic(
nanoparticles(and(ions(in(the(hydrogel' (a)(Changes(of(the(AgNP(concentrations(in(a(hydrogel(prepared(
either(by(“in!situ”(assembly,(or(“twoKstep”(assembly.(The(nanoparticle(concentrations(were(calculated(
from(the(UV/Vis(absorbance(at(the(wavelength(of(420(nm.((b)(Accumulated(ICP(quantification(of(AgNP(
(bK1)(and(Ag+(ions((bK2)(released(from(the(hydrogel(composites.(In((bK1)(and((bK2),("In!situ+VP"(indicates(
that(the(AgNPKPEGDAKPVP(hydrogel(composite(prepared(by(the(in!situ(assembly.(
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Figure'5.11'Antimicrobial(activities(of(the(AgNPKhydrogel(composites(against(E.(coli(strains(in(media.((a)(
Changes(of( the(optical(density(at(wavelength(of(600(nm((OD600)(over( time,(when(E.( coli(growth( in( the(
broth(media(was(challenged(by(the(AgNPKhydrogel(composites(prepared(with(different(concentrations(
of( silver( nitrate.( Initial( E.( coli( concentration( was( 1.5( x( 106( (CFU)/mL.( The( lag( time( (Lg)( (aK2)( and( the(
growth( rate( (GR)( (aK3)( of( cells,( challenged( with( gel( composites( prepared( with( different( silver( nitrate(
concentrations.((b)(Changes(of(OD600(over(time(when!E.(coli(growth(in(the(broth(media(was(challenged(
by(the(AgNPKhydrogel(composites(with(different(compositions.(The( lag(time((bK1)(and(the(growth(rate(
(bK2)( of( cells( challenged(with( gel( composites(with( different( compositions.( "None”( represents( the( cell(
suspension(not(exposed(to(any(gel(composites,(“PEGDA”(does(that(incubated(with(the(pure(PEGDA(gel,(
“+VP”( does( that( incubated( with( the( pure( PEGDAKPVP( hydrogel,( “+Ag”( does( that( incubated( with( the(
AgNPKPEGDA(gel(composite,(and(“+Ag+VP”(does(that(incubated(with(the(AgNPKPEGDAKPVP(gel.((All(gels(
were(prepared(via(the(in!situ(assembly.((
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Figure' 5.12( Evaluation( of( the( longKterm( antiKbacterial( activity( of( the( hydrogel( composites.( Hydrogel(
composites(were( incubated( for( 10( days( in( DI(water( before( adding( them( into( the( cell( suspension.( (a)(
Optic(images(of(E.(coli(cell(suspension(challenged(by(the(gel(composites(over(24(hours.(“Two(step”(and(
“In!situ”(represent(the(AgNPKPEGDA(hydrogel(composites(prepared(by(the(twoKstep(and(in!situ(assembly(
with( 0.2( mM( silver( nitrate,( respectively.( (b)( Absorbance( intensity( of( cell( suspension( measured( at(
wavelength(of(600(nm.(
  
None% Two(step% In#situ# In#situ+VP%
(a) 
(b) 
Long-term OD
None Two-step In situ In situ+VP
0.0
0.2
0.4
0.6
None
Two-step
In situ
In situ+VP
Sample type
O
D
60
0 
(A
.U
.)
97 
 
 
 
 
 
 
 
 
Figure' 5.13( Fluorescence( images( of( the( hydrogel( surface( exposed( to( the( tdTomato( fluorecenceK
expressing(E.( coli.( “PEGDA”( represents( pure( PEGDA(hydrogel.( “Two( step”( and( “In! situ”( represent( the(
AgNPKPEGDA(hydrogel( composites( prepared(by( the( twoKstep( and( in! situ( assembly(with( 0.2(mM( silver(
nitrate,(respectively.(“In!situ(+(VP”(represent(the(AgNPKPEGDAKPVP(hydrogel(composites(prepared(by(in!
situ(photoKactivated(crossKlinking(reaction.(The(images(were(captured(after(incubation(over(7(days.(
( (
I.#PEGDA# II.#Two,step# III.#In#situ# IV.#In#situ#+#VP#
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Figure'5.14'Mitigation(of(biofilm(formation(on(nylon(and(aluminum(substrates(using(the(AgNPKPEGDAK
PVP(hydrogel(composite(as(a(coating(material.( (a)(A(scheme(depicting(sequential( surface(activation(of(
target(substrates((step(1)( followed(by( immobilization(of(the(AgNPKPEGDAKPVP(hydrogel(composite.( (b)(
Optic( (left)( and( fluorescence( (right)( images( of( tdTomato( fluorescence( from( the( uncoated( and( coated(
substrates.(Images(in((bK1)(represent(the(nylon(substrate(and(those(in((bK2)(do(the(aluminum(substrate.((
(c)(Quantification(of(the(fluorescence(yield(from(the(nylon(and(aluminum(substrates(either(uncoated(or(
coated( by( the( AgNPKPEGDAKPVP( hydrogel( composites.( (d)( SEM( images( of( bacteria( collected( from( the(
nylon(surface(either(uncoated(or(coated(by(the(gel(composites.((
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CHAPTER 6 
 
CONCLUSION 
 
In this study I summarized prior approaches taken to enhance a PEGDA hydrogel’s ability to 
control molecular release and underlined key challenges (i.e., molecular damage and an 
uncontrollability of release direction) that should be still solved. As alternative methods, I 
developed the advanced in situ formations of a PEGDA hydrogel as for biomacromolecular 
delivery and metallic nanoparticle carrier. The significance of this study lies in (1) incorporating 
the idea and science of bimetallic strips into fabricating the self-folding multi-walled hydrogel, 
(2) controlling the release rate and direction of macromolecular drugs with the self-folding 
hydrogel for revascularization therapies, (3) introducing therapeutic patch delivery system that 
can be applied to diverse bio-patches like flexible electronic devices and cell sheets using the 
self-folding technique with degradable hydrogel, and (4) controlling release of metal 
nanoparticles in a hydrogel for anti-bacterial/fouling applications via in situ assembly of metal 
nanoparticles-hydrogel composites. Overall, this study should greatly serve to enhance the 
efficacy of multiple, molecular compounds used for diverse agricultural products, food additives, 
sensor devices, and clinical treatments. 
( (
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